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Summary 
The addictive drug ethanol represents a serious universal health and social problem. Alcohol 
abuse and dependency have been increasing in many countries worldwide. Chronic use of 
alcohol leads to metabolic abnormalities and damage to the brain, which can result in severe 
cognitive dysfunction and addiction. Areas of the brain such as prefrontal cortex (PFC), the 
white matter, the hippocampus (HP), the cerebellum and the striatum are particularly vulnerable 
to the effects of alcohol. The striatum (ST), a region of brain closely associated with addiction 
mechanisms, is commonly divided into two regions, dorsal (DS) and ventral striatum (VS); the 
DS comprising caudate nucleus (CN) and putamen (P) while the VS is constituted mainly by 
nucleus accumbens (NAc). Neuroimaging analysis indicates that microstructural degradation is 
occurring in alcohol-affected brains and the abnormalities may be correlated with altered 
locomotor activity, aggressive behavior, changes in reward/aversion-related learning, deficient 
motor coordination, disturbances in procedural learning and memory. The NAc is strongly 
implicated in drug addiction but current evidence suggests that DS has also a significant role in 
this process.  One of the aims of the project is to carry out comparative study of the sub-regions 
of human alcoholic striatum using two omics technologies (proteomics and metabolomics). 
There were no differences in the levels of dopamine (DA), 3,4-dihydrophenylacetic acid 
(DOPAC), serotonin (5HT), homovanillic acid (HVA), 5-hydroxyindoleacetic acid (HIAA), 
histamine, L-glutamate (Glu), -aminobutyric acid (GABA), tyrosine (Tyr) and tryptophan 
(Tryp) between the DS (CN and P) and VS (NAc) in control brains. Choline (Ch) and 
acetylcholine (Ach) were higher and, norepinephrine (NE) is lower, in the VS Overall. Alcohol-
affected ST had lower levels of neurotransmitters except for Glu (30% higher in the alcoholic 
ventral striatum). Ratios of DOPAC/DA and HIAA/5HT were higher in alcohol-affected ST 
indicating an increase in the DA and 5HT turnover. Glutathione was significantly reduced in all 
three regions of alcohol-affected ST. The pattern of changes of 13 neurometabolites in alcoholic 
sub-regions relative to their respective control was similar.  In order to investigate correlations 
between the alcohol-related changes in metabolites and and altered protein expressions, the 
author has selected a single sub-region of ST for a global proteomics study. By analysing CN 
tissues, 25 unique proteins were found to be differently expressed in alcohol-affected tissue 
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relative to control. From the identified proteins two were dopamine-related proteins and one a 
GABA-synthesizing enzyme glutamate decarboxylase (GAD) 65. Two proteins that are related 
to apoptosis and/or neuronal loss (BiD and amyloid-β A4 precursor protein-binding family B 
member 3) were increased. These results suggest that neurotransmitter metabolism and systems 
possibly related to neuroprotective mechanisms in both the DS (CN and P) and the VS (NAc) are 
significantly influenced by long-term heavy alcohol intake associated with alcoholism. Amongst 
the mechanisms mediating the effects of alcohol oxidative stress may have produce a particularly 
significant impact and could make a strong contribution to the microstructural damage. 
It has been known that alcohol can have a particularly damaging effect on the PFC and the HP 
regions of the fetus/developing/adolescent brain. The change imparted at those stages of 
development could be irreversible resulting in lasting deficits in a range of personality traits and 
impacting decision making, memory and learning. The HP is a significant place of neurogenesis 
and a source of neural stem cell (NSC). These can differentiate into neurons, astrocytes and 
oligodendrocytes and constitute building blocks of the developing central nervous system. They 
can also contribute to brain repair at later stages of development and, possibly, even in 
adulthood. On current evidence, alcohol reduces neurogenesis but little or no tangible 
information is available on the actual biochemistry and/or the fate of NSC.  
In the present experiments, the NSC obtained from rat embryos were exposed to various 
concentrations of ethanol (25 to 100 mM) for up to 96 hours. The cell numbers were found to be 
reduced in the presence of ethanol but only at the higher concentrations (50 and 100 mM). There 
were no apparent dramatic changes in the morphology of the cells but the numbers of neuron-
like (MAP2-positive) cells were reduced by ethanol in a dose-dependent manner.  In proteome 
analysis of alcoholic cells, a total of 28 proteins were altered in 50 mM ethanol relative to 
ethanol-free control. Of these proteins some were constituents of cytoskeleton, others were 
involved in transcription/translation, energy metabolism, signal transduction and oxidative stress. 
Two of the proteins identified as altered were nucleophosmin (NPM) and dead-end protein 
homolog 1 (DND1). These were further studied by immunological techniques in cultured 
neurons and astrocytes.  NPM decreased and DND1 increased in both alcohol affected neurons 
and astrocytes cells. 
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Interactome (protein-protein interaction) is a new branch of system biology, playing an important 
role in regulating various biological mechanisms including DNA replication & transcription, 
enzyme-mediated metabolism, transmembrane trafficking, signal transduction and cell cycle 
control. It is known that proteins function often if not always in the context of larger complexes 
and an adequate understanding of protein function requires at least some knowledge of their 
interactions, whether real or potential. In immunological analysis (Western blot), chronic 
excessive alcohol decreased NPM by 43% and increased DND1 by 80% in post-mortem 
alcoholic human PFC relative to healthy controls.  Interactome was performed using the protein 
extract of human postmortem PFC by shot gun proteomics. NPM showed apparently specific 
interactions with 55 proteins and the associated proteins belong to cell growth (4), cell structure 
(4), metabolism (18), oxidative stress response (5), signalling (8), apoptosis and DNA damage 
(2), epigenetics (2), transcription (7) and transmembrane proteins (5) classes. DND1 interacted 
with 24 proteins; related to cell growth (1), cell structure (2), metabolism (13), oxidative stress 
(3), signalling (3) and transcription (2). The results show that alcohol alters a very large number 
of proteins capable of dramatically altering protein homeostasis in alcoholic cells. Thus the 
ethanol exposure modifies a wide range of mechanisms needed for the function of cells – and 
this includes NSC’s eventually leading to the production of seriously impaired cells; inter alia, 
the processes of development, differentiation and repair using such cells by ethanol-exposed 
brains will result in abnormalities such as those typically encountered in the fetal alcohol 
spectrum disorder and/or in alcoholism later in life.   
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INTRODUCTION 
Alcoholism can very well be labelled “a biopsychosocial disease” to do justice to its multiple 
causes and multiple impacts on both individual and society.  Approximately 90% of Australians 
have tried alcohol by the age 14 and consumed a standard drink (10 g alcohol) by the age of 16 
(Annonymous, 2010). The rate of binge drinking is about 40% among Australian teenagers and 
its impact is probably best illustrated by everyday news (Annonymous, 2010). Early age 
(adolescent) onset of this type of alcohol consumption has been linked to the development of 
dependence in adult life (Grucza et al., 2008). Alcoholism has two types of symptoms: 
behavioral (addiction) and physiological. Behavioral symptoms include greater tolerance to 
alcohol, the presence of withdrawal symptoms upon cessation of alcohol intake, inability to 
control the desire to drink (“craving”), spending excessive time figuring out how to obtain 
alcohol and a reduction in social, recreational or working activities. The physiological symptoms 
can be broken down into two major categories: symptoms of acute and symptoms of chronic 
alcohol use. Acute use of alcohol causes several health problems such as poor balance, slurred 
speech and impaired peripheral vision.  Long-term use of alcohol causes nutritional deficiencies, 
problems with balance and walking, liver disease (including cirrhosis and hepatitis), decreased 
immunity to infections, gastrointestinal inflammation and cognitive dysfunction. Cognitive 
symptoms include memory loss, impaired planning skills, loss of verbal fluency and learning 
ability.  
Chronic use of alcohol not only alters the cellular physiology of the body but also causes specific 
organ (liver and brain) damage.  
A person’s susceptibility to alcoholism–related brain damage can be associated with their age, 
gender, drinking history and nutrition. The degree of the brain damage and related 
neurobehavioral deficits varies from brain region to brain region.   Areas of the brain that are 
especially vulnerable to alcohol–related damage are the cerebral cortex and the subcortical areas 
such as the limbic system, the thalamus, the hypothalamus, the basal forebrain  (Oscar–Berman 
2000), the  hippocampus (Ryabinin, 1998) and the cerebellum (Sullivan 2000). Volumetric 
magnetic resonance imaging (MRI) studies have consistently revealed reduced grey matter 
volumes in alcoholics. Significantly smaller volumes have been identified in the subcortical grey 
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matter, dorsolateral frontal and parietal cortices and the medial temporal lobe (Jernigan et al., 
1991). Several studies on older alcoholic adults have documented that alcohol reduces the 
hippocampal volumes as well as verbal and spatial memory impairments (Grant, 1987; Munro et 
al., 2000). Pathological (Harper et al., 1985; Kril et al., 1997) and MRI studies (Pfefferbaum et 
al., 1992) showed that the white matter (WM) atrophy is related to maximum daily alcohol 
consumption and there are decreases in WM volume (Schweinsburg et al., 2001) including 
corpus callosum (CC) (Pfefferbaum et al., 2006; Pfefferbaum et al., 2006). The shrinkage and/or 
volume change is greater in the genu of the CC followed by the other sub-regions like the body 
and the splenium. Alcohol-induced volume reduction and disruption of the structural integrity of 
the CC could result in slowing of information processing and interhemispheric transfer, leading 
to deficits and/or abnormalities of visuo-spatial ability, gait, balance and working memory 
(Pfefferbaum et al., 2006; Pfefferbaum et al., 2006). Moreover, slight reductions in the volume of 
grey matter have also been shown in the putamen and the caudate nucleus (Norman et al., 2009). 
Striatal structural alteration and abnormal metabolism were shown in a child prenatally exposed 
to drugs including methamphetamine and these structural changes were accompanied by deficits 
in cognitive functions (Roos et al., 2014, Chang et al., 2007). Pathogenic mechanisms underlying 
the micro structural changes of the brain regions, only some of which appear to be reversible, are 
largely unknown.  
Most of our attention has been on the problems of alcohol abuse and alcohol dependence in the 
adult; however, consequences of alcohol on fetus/unborn and/or newborn baby has been 
neglected and the disorders are collectively called Fetal Alcohol Spectrum Disorder (FASD). 
The prevalence of FASD might be as high as 1 to 5% in young school children in the USA (May 
et al., 2009; Lipton et al., 2004), which is apparently higher than the prevalence rate in Australia 
(Sokol et al., 2004). A study with FASD in indigenous Australians revealed that 540 out of 
614 children under the age of 12 have signs of primary and secondary disabilities associated with 
FASD (Plevitz et al., 2009).  The prevalence of FASD is 2 to 3 times as high as that of non-
indigenous children (Harris and Bucens, 2003; Bower et al., 2000).  
Those who get used to drinking regularly while young may find it difficult to stop when they 
reach the age when reproduction normally takes place. Regular heavy drinking (4 or more 
standard drinks in one sitting at least once weekly) or binge drinking (more than 5 drinks in one 
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sitting), particularly in the first trimester of pregnancy, is strongly associated with FASD-related 
characteristics (Elliott et al., 2008). Impairments associated with FASD are often a reflection of 
underlying structural changes in the brain, as evidenced above by changes in the corpus callosum 
(Spadoni et al., 2007). An MRI might also reveal decrease in brain size, damage to the basal 
ganglia, or reduced size of the cerebellum (Spadoni et al., 2007). Alcohol related brain deficits 
can manifest as either structural changes such as microcephaly, agenesis of the corpus callosum 
or cerebellar hypoplasia; or functional deficits affecting behaviour and cognition (Spadoni et al., 
2007). The molecular mechanisms of the impact of alcohol on developing brain are still being 
uncovered.  
The hippocampus (HP) is a site of neural stem cell production and neurogenesis and if these are 
impaired, whether pre- or postnatally it will result in an abnormal behavior later in life (McKay, 
1997, Lledo et al., 2006). Neural stem cells (NSC) are pluripotent cells capable of differentiating 
into neurons, and glia including astrocytes and oligodendrocytes. The NSC play a pivotal role in 
the development and maturation of the CNS and migrate first to form specific brain regions 
while, later in the life, the “adult neurogenesis” may represent a response to functional demands 
or a replacement for damaged cells (Lledo et al., 2006). NSC proliferation, differentiation, cell 
migration and integration into the context of the tissue are affected by abiotic (eg. drugs, alcohol, 
antipsychotic agents etc) factors (McKay, 1997, Lledo et al., 2006). Administration of moderate 
doses of ethanol for 6 weeks has been shown to reduce the number of new neurons by two thirds 
and increase (by 227–279% relative to controls) the rate of cell death in the dentate gyrus 
(Herrera et al., 2003). Experiments using low to high concentration of ethanol in 35–40 days old 
rats indicated that adolescent brain is particularly sensitive to acute ethanol and displays, in 
addition to other changes, significantly decreased neurogenesis (Crews et al., 2006). Prenatal 
exposure to ethanol has long-lasting depressive effects on postnatal neurogenesis in the 
subgranular zone of the dentate gyrus and such abnormal neurogenesis may have a serious 
impact on brain health in later life (Redila et al., 2006; Klintsova et al., 2007). Longer exposures, 
such as a 4-day binge model, have been reported to result in reduced cell proliferation and 
impaired survival of NSC (Morris et al., 2010; Nixon and Crews, 2002). Moreover, ethanol at 
high concentration (50 mM) affects both the proliferation of NSC and gliogenesis, leading to 
concomitant changes in the glial phenotype; it has been suggested that ethanol can alter intrinsic 
cellular mechanisms of stem cells eventually impacting on the functional characteristics of both 
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neurons and glial cells (Vemuri et al., 2005). For example, such cells may have impaired 
genomic or biochemical makeup caused by remodeling of chromatin via ethanol-induced 
changes in acetylation and deacetylation of histones H3 and H4. This may happen in various 
brain regions [prefrontal cortex, nucleus accumbens, and striatum (MacDonald and Roskams, 
2008; Wit, 2010)] and the existence of such damaged cells may possibly contribute to functional 
deficits in those regions (Liyanane et al., 2014; Stragier et al., 2015; Bonnaud et al., 2016). 
 Researchers have been interested not only in the genes that could contribute to the development 
of alcoholism but are increasingly looking into the functional activities of the proteins encoded 
by the genes. Many genetic approaches including QTL (quantitative trait locus)  have been 
applied to study the polymorphisms in genes that may increase susceptibility to alcoholism. 
However, this search has been slow because the traditional molecular biology approaches are 
focused on the quantification of mRNA levels and generally target one or a few genes. The 
recent developments in system biology including DNA microarray studies have allowed for a 
nonbiased, simultaneous measurement of the expression of thousands of genes that are related to 
the ‘downstream’ effects of alcoholism (Xu et al., 2001; Kerns et al., 2005; Thibault et al., 2000; 
Lewohl et al., 2000). However, this generated a bounty of microarray data regarding the 
biological effects of ethanol, and to make the most effective use of this wealth of information, it 
will require the identification of the corresponding proteins. There are several reasons why 
studying the  proteins produced by a cell can be more useful than examining mRNA expression 
in trying to understand the processes contributing to the cell’s normal and pathological 
functioning. Firstly, RNA expression often does not correlate with protein expression (Celis et 
al., 2000).  Secondly, miRNA (MicroRNA) interferes with the protein expression at the 
translation level. Thirdly, the activity of a protein could be significantly modulated by post-
translational modification, which cannot be detected at the level of RNA. Fourthly, proteins are 
normally much more stable than RNA not only in cells, but particularly in the isolated body 
fluids and postmortem tissues.  Thus, the study of proteins seems absolutely crucial for 
elucidating the cellular role of gene products apart from presenting a potential gold mine for 
understanding the cellular mechanism in the stem cell.  
High-throughput proteomics technology is rapidly achieving recognition as a complimentary and 
superior approach to examine global changes in protein expression in complex biological system 
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and, this technology is also very useful for novel targets for medications, biomarker development 
and the understanding of the molecular mechanism of different diseases. Using proteomics 
approach, Lewohl et al., (2004) examined postmortem superior frontal cortex in alcoholism 
versus control tissue and identified 182 proteins which were differentially expressed in 
alcoholics; of these, 139 showed significantly lower expression, 35 showed significantly higher 
expression, and 8 were “new” or had disappeared in alcoholics. Proteomic based differential 
protein expression has been studied in postmortem human alcoholic in the prefrontal gray and 
white matter (Alexander-Kaufman et al., 2006; Alexander-Kaufman et al., 2007a), cerebellar 
vermis (Alexander-Kaufman et al., 2007b), sub-regions of the CC (Kashem et al., 2007; Kashem 
et al., 2008; Kashem et al., 2009a) and the hippocampus (Matsuda-Matsumoto et al., 2007) and 
the striatum of alcoholic rat brain (Kashem et al., 2012). Screening of more than 7000 proteins in 
various regions of brains mostly in the neocortex and HP, author has identified 238 proteins that 
were associated with alcohol induced abnormal metabolic disorders. According to their putative 
functions of these proteins can be classified as cytoskeletal (16%), metabolic (42%), oxidative 
stress-related (15%), signaling (22%) and apoptosis-related (5%). These results suggest that 
alcohol alters a very large number of proteins expressed in the cell thus almost certainly altering 
concomitantly the very mechanism of the cell homeostasis. 
It has been estimated that at least 80% of proteins function in the form of complexes. The 
protein-protein interaction (PPI) (i.e. interactome) plays an important role in regulating various 
biological mechanisms including DNA replication & transcription, enzyme-mediated 
metabolism, transmembrane trafficking, signal transduction and cell cycle control (Berube et al., 
2005). PPI is crucial for neurotransmission in the brain; for example whole release mechanism of 
neurotransmitter molecules depends on a precise and complex regulation of PPI (Chang and Min, 
2011). As for other examples, ion channel or neurotransmitter transporter proteins located in the 
synaptic membrane have been regulated by complex protein interactions (Jackson and Robinson 
2016). Identification and characterization of the PPI is important for our understanding of the 
metabolic processes that occur during normal neurotransmission and might provide new insights 
into cell function adaptations in the presence of alcohol. Therefore the study of interactome will 
certainly deepen and improve our understanding of diseases and, importantly, could provide the 
basis for new therapeutic approaches.  
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The traditional approach of biomarker discovery which usually focuses on one or a few potential 
candidates at a time is often ineffective for clinical diagnosis.  Alcohol is a multifactorial 
addictive drug which affects many biological processes. It interacts with DNA, RNA and 
proteins and the result is an alteration of metabolism in the whole body. Several traditional 
alcohol biomarkers such as gamma-glutamyl transferase (GGT), aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), and carbohydrate-deficient transferin (CDT) have been 
used for many years. Out of the identified  238 proteins, some proteins such as tyrosine 
hydroxylase, dopamine--hydroxylase, catechol-O-methyltransferase, DOPA decarboxylase, 
tryptophan hydroxylase, glutamate decarboxylase-2, glutamate synthetase, N-acetylaspartate-
glutamate synthetase, glutamate carboxypeptidase II, histidine decarboxylase, glutathione 
peroxidase, glutathione synthase, glyoxalase-1, apolipoprotein A-I, triosephosphate isomerase, 
isocitrate dehydrogenase,  phospholipase D,  SNAP-25, stathmin, sirtuin-2, DJ-1, α-synuclein, 
protein phosphatase, DARPP-32, CREB, apoptic death agonist (Bid) and cathepsin D have the 
greatest potential to become biomarkers for alcoholism and alcohol-related disorders. However, 
using other recently developed techniques such as metabolomics point to subtle changes in 
genes, transcripts or protein levels that can cause substantial changes in the levels and dynamics 
of metabolites and many studies reported identification of metabolite-based biomarkers for 
neurological disorders including Alzheimer disease (AD) and Parkinson disease (PD)  
(Nicholson et al., 2012; Xia et al., 2013; Kaddurah-Daouk and Krishna, 2009; Trushina et al., 
2013). Alcohol alters the microstructure of the brain and causes brain damage and early detection 
of these changes would be the most effective way to improve the clinical outcome of the disease. 
Current advances in analytical technologies promise quantification of biomarkers from even 
small amounts of bio-specimens using non-invasive or minimally invasive approaches, and 
facilitate high-throughput analysis required for real time applications in clinical diagnosis. Thus 
emerging metabolomics provides a powerful platform for discovering novel biomarkers and 
biochemical pathways to improve our understanding of early diagnosis of alcoholism and FASD.   
During the past eight years author carried out research (including the studies contributing to 
author's Master of Science degree) focusing on differential protein expression in various 
postmortem human brain regions such as the genu, body, splenium of CC, the HP and the striatal 
tissue of rats exposed to chronic alcohol. However, this provided no tangible information on 
system biology of the addiction-regulating brain region striatum. Moreover, alcohol is 
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particularly damaging to young brain; yet, has very limited knowledge of how alcohol impacts 
on the developing brain tissue, particularly at the cellular and molecular level. Given the 
fundamental importance of neural stem cells in the process of brain development, studies on rat 
neural stem cells (rNSC) cultured in the presence of alcohol were also included in the present set 
of projects. 
The main objectives of the studies discussed in the thesis are the following:  
1. To study global protein expression in selected sub regions of the striatum from human post 
mortem alcoholics.  
2. To study differential expression of metabolites in the sub regions of alcoholic human 
postmortem striatum.  
3. To identify differential protein expression  profiles in alcoholic rNSC. 
4. To study interactomes of selected proteins (in this case those of NPM and DND-1 as the two 
proteins most altered both by alcohol-treated neural stem cells and in human alcoholic brain 
tissue) in human post-mortem prefrontal cortex tissues.  
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CHAPTER 2 
Metabolomics of Neurotransmitters and Related Metabolites in Most-mortem 
Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain 
 (This chapter is based on paper published in Neurochemical Research (Kashem et al 2016. 
Neurochem Res. 41, 385-397) 
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Abstract 
 
This chapter presents a report on changes in neurotransmitter metabolome and protein expression 
in the striatum of humans exposed to heavy long-term consumption of alcohol. Extracts from 
post mortem striatal tissue (dorsal striatum; DS comprising caudate nucleus; CN and putamen; P 
and ventral striatum; VS constituted by nucleus accumbens; NAc) were analysed by high 
performance liquid chromatography coupled with tandem mass spectrometry. Proteomics was 
studied in CN by two-dimensional gel electrophoresis followed by mass-spectrometry. 
Proteomics identified 25 unique molecules expressed differently by the alcohol-affected tissue. 
Two were dopamine-related proteins and one a GABA-synthesizing enzyme GAD65. Two 
proteins that are related to apoptosis and/or neuronal loss (BiD and amyloid-β A4 precursor 
protein-binding family B member 3) were increased. There were no differences in the levels of 
dopamine (DA), 3,4-dihydrophenylacetic acid (DOPAC), serotonin (5HT), homovanillic acid 
(HVA), 5-hydroxyindoleacetic acid (HIAA), histamine (His), L-glutamate (Glu), γ-aminobutyric 
acid (GABA), tyrosine (Tyr) and tryptophan (Tryp) between the DS (CN and P) and VS (NAc) 
in control brains. Choline (Ch) and acetylcholine (Ach) were higher and norepinephrine (NE) 
lower, in the VS. Alcoholic striata had lower levels of neurotransmitters except for Glu (30% 
higher in the alcoholic ventral striatum). Ratios of DOPAC/DA and HIAA/5HT were higher in 
alcoholic striatum indicating an increase in the DA and 5HT turnover. Glutathione was 
significantly reduced in all three regions of alcohol-affected striatum. Author concludes that 
neurotransmitter systems in both the DS (CN and P) and the VS (NAc) were significantly 
influenced by long-term heavy alcohol intake associated with alcoholism.  
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Introduction 
 
As dopamine (DA) has been considered a key neurotransmitter in mechanisms leading to 
addiction, it seems natural that DA systems in brain have been studied in relationship to 
alcoholism for some time. The most powerful associations between alcohol dependence and 
genes involved in dopamine metabolism has been reported for genes DRD2 (TaqI A 
polymorphism of ANKK1 gene) and DRD4 encoding corresponding dopamine receptors D2 and 
D4 (Mota et al., 2012, Creemers et al., 2011, Zwaluw et al., 2011). Significant associations 
between alcoholism and polymorphisms in genes for enzymes monoamine oxidase (Whitfield et 
al., 2000) catechol-O-methyl transferase (COMT) (Sery et al., 2006, Voisey et al., 2011, Wang et 
al., 2001), dopamine-β-hydroxylase (DBH) (Weinshenker et al., 2000), and a serotonin 
transporter (SLC6A4);(Zwaluw et al., 2011) have also been found; however, despite many 
studies in the literature, no satisfactory understanding of neurochemical mechanisms underlying 
alcoholism has been achieved to date. 
Previouly author studied more than 7000 expressed proteins in various regions of 
alcoholic post-mortem human or rat brains and identified 238 proteins that have been associated 
with alcoholism; these have been categorized into cytoskeletal (28%), metabolic (42%), 
oxidative stress (15%), signalling-related (22%) and apoptosis-related (5%) proteins (Kashem et 
al., 2007, Kashem et al., 2008, Kashem et al., 2009a, Matsuda-Matsumoto et al., 2007, 
Matsumoto et al., 2007). The functional profiles of the altered proteins (enzymes in particular) 
have indicated that alcohol could interfere with glucose metabolism, tricarboxylic acid cycle, and 
other crucial metabolic pathways associated with thiamine, lactate, glutathione, fatty acid/lipase 
as well as the metabolism of signalling compounds such as dopamine, serotonin and glutamate 
(Kashem et al., 2007, Kashem et al., 2008, Kashem et al., 2009a). In order to follow up in more 
detail how the changes in expression of the functional proteins that author's research has already 
identified may translate into specific changes in neurochemistry of neurotransmitters and related 
metabolites author is now expanding this approach by adding metabolomic techniques to his 
investigations. Given that biochemical and physiological changes underlying development of 
drug addiction have often been traced to the striatum, author selectes this part of the brain as the 
main region of interest in the present study.  
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The striatum has been conventionally divided into caudate nucleus (CN) and putamen (P) 
but, more recently, a third sub-region has been recognized (Heimer, 2000) comprising mainly 
nucleus accumbens (NAc) at the ventral confluence of CN and P.  Striatum receives two major 
inputs: axons of excitatory pyramidal glutamatergic neurons from the cerebral cortex and an 
array of mainly dopaminergic, serotoninergic and cholinergic fibres from the brain stem. While 
the dorsal striatum (DS: CN and P) receives most of its direct cortical input from sensorimotor 
(P) or association (CN) cortex (Russo and Nestler, 2013), ventral striatum (VS: NAc) is targeted 
mainly by the areas of the cerebral cortex concerned with motivational or emotional activities 
and include insula, temporal lobe, anterior cingulate gyrus, parts of prefrontal cortex (PFC) and 
hippocampus (Dichter et al., 2012). Dopaminergic innervation of the VS originates mainly in the 
ventral tegmental area (VTA) of the brainstem and, to a lesser extent, in the medial substantia 
nigra (Andrisani, 1999, Hjelmstad et al., 2013). The DS receives its dopaminergic input from 
substantia nigra, pars compacta. Interestingly, the VTA dopaminergic fibres also release 
glutamate (Chuhma et al., 2009, Trudeau et al., 2014). Functional differences between the dorsal 
and ventral striatum could be reflected in neurochemical differences; this would agree with 
authors previous proteomic studies of human brain (Kashem et al., 2009b).  
In terms of cytoarchitecture, medium-sized densely-spiny GABAergic neurons constitute 
the principal neuronal population and the only projection neurons in both dorsal and ventral 
striatum accounting for 75-80% of all striatal neurons in human brain (Tepper et al., 2004). The 
remainder is formed by local interneurons, the majority of which are also GABAergic (Tepper et 
al., 2004, Kreitzer, 2009). There is a small but functionally significant indigenous population of 
cholinergic interneurons throughout the striatum.  
While no sharp boundary between the dorsal and ventral striata can be established on the 
basis of cytoarchitecture, myeloarchitecture or chemoarchitecture (Heimer , 2009, Prensa et al., 
2003), accumulated evidence indicates that there exists a functional heterogeneity within the 
structures (Prensa et al., 2003, Tran-Nguyen et al., 1996). The VS appears to regulate the overall 
level of locomotor activity, aggressive behaviour and reward/aversion-related learning (Koob 
and Volkow, 2010) while DS is more intimately involved in motor coordination and procedural 
learning (Beeler et al., 2010, Dang et al., 2006). The circuitry involving the dopaminergic input 
from VTA to NAc seems crucial for processing of incentive-motivational properties of drugs and 
drug-related cues while other regions such as the amygdala and the hippocampus (HP) are more 
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likely to contribute to the habitual learning behavior which could also be a part of the addiction-
forming mechanism (O'Brien and Gardner,2005). A model of neuronal networking regulating 
human addiction process as proposed by Volkow et al. (2003) includes the following: (a) reward 
and drug seeking circuits mediated by the NAc, (b) motivation/drive located in the orbitofrontal 
cortex and the subcallosal cortex, (c) memory and learning mediated by DS, the amygdala and 
the HP and (d) the cortical control executed from the PFC and the anterior cingulate gyrus 
(Volkow et al., 2003).   
The overall evidence therefore suggests that, even though the VS is anatomically and/or 
cytoarchitecturally similar to DS, the functional activities related to addiction could be very 
different and this may be reflected in the regional neurochemical make up, as author has noted in 
his previous study using proteomics in otherwise apparently homogenous sub-regions of the 
corpus callosum (Kashem et al., 2009a). Here author looks for such differential neurochemical 
changes; particularly for those associated with neurotransmitters and cellular signalling. 
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Materials and Methods 
 
Chemicals 
Dopamine hydrochloride (DA), serotonin hydrochloride (5HT), tyrosine (Tyr), 
tryptophan (Tryp), homovanillic acid (HVA), 3,4-dihydroxyphenylacetic acid (DOPAC), 5-
hydroxyindole-3-acetic acid (5-HIAA), norepinephrine (NE), γ-aminobutyric acid (GABA), L-
glutamic acid (Glu),  histamine (His), choline (Ch),  acetylcholine (Ach), glutathione (GSH), 
heptafluorobutyric acid (HFBA) and internal standard  3,4-dihydroxybenzylamine (DHB) were 
purchased from Sigma–Aldrich (St. Louis, MO, USA). HPLC grade methanol and formic acid 
were also supplied by Sigma–Aldrich and ultrapure water was obtained from a Milli-Q Gradient 
water system (Millipore, Bedford, MA, USA). All consumables for gel electrophoresis were 
obtained from Proteome Systems Ltd (Australia) and IPG (immobilized pH gradient) strips were 
from Biorad Lab Pty Ltd (Australia). 
Human brain tissue 
In this study, author used post-mortem brains from 12 males. The samples came from 6 
control and 6 alcoholic brains. Mean age in groups, alcoholics and controls was 59 years (cf. 
Table 1 for further details). All post-mortem human brains were obtained from the NSW Brain 
Bank (University of Sydney). The tissue samples were taken from the caudate nucleus (CN), the 
putamen (P) and the nucleus accumbens (NAc). The groups were, as far as possible, matched for 
age and pH (except for the post-mortem interval; PMI, of 3 alcoholic samples). Post-mortem 
examination of the alcoholic brains revealed that there were no complications from Wernicke-
Korsakoff Syndrome (WKS) in any of the alcoholic brains used in the present study. Clinical 
history of the patients indicated that patients did not suffer from any additional psychiatric or 
neurological diseases unrelated to their alcoholic condition. Death of the patients was not directly 
caused by any known dysfunction of the central or peripheral nervous system. Alcoholic cases 
fulfilled the criteria of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) 
for alcohol dependence (Annonymous 1994). Alcohol consumption data were obtained from 
medical records or from reports by the next of kin. Ethics approval for human tissue use was 
obtained from the Sydney South West Area Health Service.  
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Table 1. Patients Demography 
------------------------------------------------------------------------------------------------------------------------ 
Brain Bank Code   Age (Yrs) PMI (hrs) Brain pH Cause of Death 
--------------------------------------------------------------------------------------------------------------------------------------- 
Control brains 
 650    37  14.5  6.46  Cardiomyopathy 
 582    50  30  6.37  Coronary artery 
 583    59  40  6.53  Ischaemic heart disease 
 442    63  24  6.94  Atherosclerotic coronary heart 
 603    73  38.5  6.28  Acute myocardial infraction 
 278    74  10  6.22  Respiratory arrest 
________________________________________________________________________________________ 
 Mean ± SEM                  59 ± 6                   26.2 ± 5.0           6.50 ± 0.11  
Alcoholic brains 
 332    41  54  6.70  Epilepsy & chronic alcoholism 
 330    50  60  6.75  Chronic airflow limitation 
 597    59  35  6.57  Coronary artery thrombosis 
 533    63  25.5  6.21  Ischaemic heart disease 
 313    70  62  6.82  Cardiomyopathy 
 512    73  43.5  6.59  Coronary artery atheroma 
__________________________________________________________________________________________ 
 Mean ± SEM  59 ± 5             46.7 ± 5.9              6.61 ± 0.09  
Preparation of standards and calibration curves for liquid chromatography/tandem mass 
spectrometry (LC–MS/MS) 
Standard stock solutions were prepared in a 0.1M formic acid solution to assist 
dissolution and minimize oxidation of labile samples (Gonzala et al., 2011). These solutions 
were stored at −20°C until use. Standard curves were prepared by adding analytes (Tyr, Tryp, 
DA, DOPAC, NE, 5HT, GABA, Ch, Ach, His, 5HIAA, HVA, Glu, GSH and internal standard 
DHB to a 0.1% formic acid solution. A constant amount (500 pg/μl) of internal standard was 
added to all standard solutions to produce a fixed concentration.  
Sample preparation for LC-MS/MS 
The brain samples were weighed and homogenized at 1 mg per 50 μL of 0.1M formic 
acid (Xu et al., 2011, Wei et al.,2014). The internal standard (DHB) was then added to 500 pg/μL 
final concentration. The suspension was sonicated and centrifuged at 16,000 x g for 20 min at 
4°C. The supernatant was filtered and diluted within the range of calibration curve.   
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Table 2. The analytical parameters of metabolitesa estimated in the extracts of postmortem 
human brain by LC-MS/MS 
------------------------------------------------------------------------------------------------------------------- 
Analytes            RT (min) Cone voltage (v)   Quantitation transition Confirmation transition 
__________________________________________________________________________________ 
Glu  0.49-0.51  25  148.3>84.1 (15)b 148.3>130.1 (10) 
GABA  0.64-0.66  35  104.0>0.1 (10)             104.3>58.1 (25) 
Chl  0.7-0.71  20  104.3>87.1 (10)            104.3>69.1 (15) 
GSH  0.76-0.77  12  308.096>75.99 (20) 308.096>179.048 (26) 
NE  0.83-0.85  12  170 >106.9 (20)             170 >1152.0 (8)  
Ach  1.03-1.07  25  146.2>87.1 (15)             146.2>43.1 (15) 
His  1.18-1.19  10  112.2 >95.1 (20) 112.2 > (8) 
Tyr  1.51-1.52  18  182.1>136.0 (14) 182.1>165.0 (10) 
DA  1.56-1.58  20  154.2>137.1 (10) 154.2>91.0 (25) 
DOPAC 1.99-2.04  20  169.1>123.1 (10) 169.1>77.1 (30) 
5HIAA  2.16-2.21  30  192.2>146.2 (25) 192.2>91.2 (35) 
5-HT  2.25-2.26  18  177.2>160.2 (10) 177.2>132.1 (20) 
HVA  2.50-2.55  22  183.2>137.2 (10) 183.2>122.0 (25) 
Tryp  2.63-2.64  18  205.1>188.1 (10) 205.1>146.0 (18) 
___________________________________________________________________________________ 
aAbbreviations: Dopamine (DA), serotonin (5HT), tyrosine (Tyr), tryptophan (Tryp), homovanillic acid 
(HVA), 3,4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindole-3-acetic acid (5-HIAA), 
norepinephrine (NE), γ-aminobutyric acid (GABA), L-glutamic acid (Glu),  histamine (His), choline 
(Ch),  acetylcholine (Ach), glutathione (GSH), bCollision energy (eV) is given in brackets. 
Analysis of metabolites  
Chromatographic analyses have been performed in an Acquity UPLC™ system (Waters, 
Milford, MA, USA), using a BEH C18 column (150 mm × 2.1 mm; Waters), with 1.7 μm particle 
size (Gonzala et al., 2011, Xu et al., 2011). The mobile phase for elution was a gradient 
established between solvent A (0.05% formic acid in water + 1mM HFBA) and solvent B 
(methanol) at a flow rate of 200 μL/min. Gradient conditions were: 0.0–1.0 min, 5–50% B; 1.0–
2.0 min, 50–95% B; 2.0–3.0 min, 95% B; and back to 5% B in 1.0 min. Flow rate was 
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0.2 mL min−1, injection volume 5 μL (in partial loop mode), the column temperature was 
maintained at 25-27°C and the sample temperature was at 4°C.  
Mass spectrometric detection was carried out using a Waters Acquity TQD tandem 
quadrupled mass spectrometer (Waters, Manchester, UK) (Gonzala et al., 2011). The tandem 
mass spectrometer was operated in multiple reactions monitoring (MRM) mode and Q1 and Q3 
quadruples were set at unit mass resolution. The instrument was operated using electro spray 
ionization (ESI) source in positive mode. ESI parameters were capillary voltage 3.0 kV, extractor 
voltage 3 V, source temperature 120°C, desolvation temperature 350°C, cone gas flow 80 L/h 
and desolvation flow 600 L/h (both gases were nitrogen). Collision-induced dissociation was 
performed using argon as the collision gas at the pressure of 4 × 10−3 mbar in the collision cell. 
The MRM transitions as well as the cone voltages and collision energies are shown in Table 2. 
Data acquisition was performed using MassLynx 4.0 software with QuanLynx program 
(Waters). Protein assay was performed by the Bradford method using bovine serum albumin as a 
standard (Bradford, 1976). 
Preparation of tissue extracts for proteomics and two-dimensional gel electrophoresis: 
Protein extraction and gel analysis were done as previously described in detail (Kashem 
et al., 2008, Hjelmstad et al., 2013, Kashem et al., 2009a). Briefly, 100 mg of tissue was 
homogenised, sonicated (3х) and centrifuged at 16000 x g for 20 min at 15°C. The supernatant 
was reduced and alkylated in 5 mM tributyl phosphine and 10 mM acrylamide monomer at room 
temperature for 2 h. The reaction was quenched using 10 mM DTT (dithiothreitol). Acetone (five 
times of extract volume) and citric acid (20 mg) and the resulting precipitate centrifuged at 2500 
x g, 15 min at 15°C. The pellet was air dried, resuspended and stored at -80°C before isoelectric 
focusing. Following protein estimation, 2-DE was conducted as previously described using SDS-
PAGE (sodium dodecyl sulphate - polyacrylamide gel electrophoresis); (Kashem et al., 2012, 
Kashem et al., 2009a, Kashem et al., 2008,Kashem et al., 2007, Kashem et al., 200b). 
Image analysis, Matrix-assisted laser desorption/ionization (MALDI)-mass spectroscopy 
and protein identification 
A total of 24 gels (duplicate runs for each sample) were scanned using a flatbed scanner 
(UMAX, USA). The images were analysed by Phoretix 2D Expression software (Nonlinear 
Dynamics Ltd, UK) and quantified (spot area x optical density, background subtracted). 
Following log transformation and normalization, one-way analysis of variance (ANOVA, p < 
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0.05) was performed to identify significant differences (spot volume) between alcoholic and 
control brains. 
The spots so identified were de-stained using 25 mM NH4HCO3/50% (v/v) acetonitrile 
(ACN) for 3 x 15 min at 37°C. The gel portions were then dehydrated using 100% ACN and 
digested with 12.5-ng/ml trypsin (Roche, sequencing grade, Germany) buffer {25 mM 
NH4HCO3/0.1% TFA (trifluoroacetic acid)} for 45 min at 4°C and incubated a further 3 hours at 
37°C. The peptide mixtures were purified using C-18 purification tips (Eppendorf, Germany), 
eluted onto a MALDI sample plate with 3 µL of matrix solution {5 mg/mL solution of α-cyano-
4-hydroxycinnamic acid in 70% (v/v) ACN/0.1 %( v/v) TFA} and allowed to air dry. The 
samples were analyzed using Qstar XL Excell Hybride MS system (AB Applied Biosystems, 
Foster City, CA, USA) in positive reflector mode, with delayed extraction. The data from mass 
spectra were matched to the Swiss-Prot database (http://www. matrixscience.com/) using criteria 
based on a MOWSE (Molecular Weight Search) score (>64, human database) with matched 
isoelectric pH (pI), molecular weight values (estimated from 2D gels) and sequence coverage. 
Statistical analyses 
Each sample was measured twice and each group contained 12 data points. All data were 
statistically analysed using single factor ANOVA. Accordingly, the mean of the two groups is 
considered to be statistically significant only if p < 0.05. Pearson correlation was performed on the 
estimates of metabolite levels and on the values of agonal factors. 
Protein extraction and Western blot (WB) analysis:  
 Striatum protein extractions were performed according to the method previously described by 
Kashem (Kashem et al., 2007, Kashem et al., 2008, Hargreaves et al., 2009). Protein were 
separated and transferred to PVDF (polyvinylidene difluoride) membranes according to a 
protocol described earlier (Kashem et al., 2012). The membranes were blocked with 5% skim 
milk and incubated with primary antibodies [all primary antibodies obtained from Santa cruiz 
and dilutions were ranged from 300-500)] solution. Secondary antibodies (anti-mouse and anti-
rabbit IgG; Sigma) were added according to the manufacturer's instructions and the resulting 
spots were visualized using an ECL (enhanced chemiluminescence) full spell system (GE 
Healthcare, Australia). The intensity of spots was quantified by commercially available Bio-rad 
software (Bio-rad, Sydney, Australia). 
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Results 
 
General 
Control brains (CB) and alcoholic brains (AB) were matched for age, brain pH and post-
mortem interval time (PMI) (Table 1). The only significant difference between alcoholic brains 
and control brains was in PMI but, even there, the overlap between the two groups was quite 
large. Available evidence suggest that PMI has no significant effect on GABA, amino acid and 
biogenic amine contents of brain tissue  (Korpi et al., 1987, Spokes et al., 1980), and, 
additionally, previously published data indicated that agonal factors had no effect on the 
expression of proteins, including those acting as enzymes in neurotransmitter metabolism, in 
several regions of post-mortem human brain (Kashem et al., 2007, Kashem et al., 2008, Kashem 
et al., 2009). As Pearson correlation statistical test showed no significant difference between 
agonal factors and metabolite expression author assumed that the data in this study are free from 
the effects of agonal factors. 
Regional Variations in Metabolite Levels 
Analyses of the metabolites in sub-regions (CN, P and NAc) of striatum in control brains 
showed no significant differences in the levels of metabolites from one sub-region of striatum to 
another except for NE, Ch and Ach contents (Table 3). In the control brains striatum, Ch and 
Ach were, resp. 58% and 70% higher, and NE 40% lower, in the NAc relative to the DS 
(represented as mean of the values in CN and P, resp.; Table 3). 
Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum: 
Catecholamines 
The levels of DA, NE, DOPAC, HVA and their precursor amino acid Tyr were 
significantly decreased in all subregions of alcoholic brains striatum compared to control brains 
(Table 4). DA reduction was similar in all sub-regions (~ 60%). The decline rates of other 
catecholamine metabolites appeared somewhat variable but the regional variability was not 
statistically significant (Table 4).   
The increase in the ratio of DOPAC/DA observed in alcoholic brains was significantly 
higher in the VS (76%) than in the DS (~ 18%);(Table 4).  Similarly, the increase in HIAA/5HT 
ratio was higher in the NAc (34%) than in the DS (Table 4).  
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Table 3. Region specific levels of metabolites and their ratios in the striatal regions of post 
mortem human brains (non-alcoholic controls) 
------------------------------------------------------------------------------------------------------------------------ 
The levels are expressed as nmole/g tissue (or † μmole/g tissue) ± SEM (n =6). Asterisks (*) mark where 
the values vary among the regions at P < 0.05 level, at least. 
Metabolites   Caudate N.   Putamen  N. accumbens P value 
________________________________________________________________________________ 
DA    32.45  ±  3.38 29.56  ± 0.67 30.13  ±  3.40 0.75 
DOPAC    17.65 ± 0.36 17.55 ± 1.13 16.04 ± 0.39 0.24 
5HT   1.42 ± 0.05 1.32  ± 0.04 1.31 ± 0.05 0. 6 
NE    1.98 ± 0.44 1.89 ± 0.09 1.15 ± 0.09 0.002* 
HVA    31.24 ± 1.63 40.60 ± 3.85 28.85 ± 1.63 0.055 
HIAA    5.44 ± 0.38 6.51 ± 0.76 4.89 ± 0.66 0.09 
Histamine   6.22 ± 0.77 4.95 ± 0.29 6.31 ± 0.62 0.189 
Choline†   3.24 ± 0.25 4.26 ± 0.61 5.86 ± 0.93 0.04* 
Acetylcholine   0.97 ± 0.08 1.16 ± 0.17 1.81 ± 0.14 0.003* 
Tyrosine    756  ±  33 788  ± 45 820 ± 33 0.58 
Tryptophan    220  ± 16 244 ± 17 260  ± 16 0.22 
Glutamate†    23.3 ± 2.0 26.9 ± 1.9 23.5 ± 1.7 0.58 
GABA    742 ± 38 790 ± 72 811 ± 53 0.68 
Glutathione†    9.57 ± 1.69 11.85 ± 2.17 11.34 ± 1.98 0.694 
---------------------------------------------------------------------------------------------------------------- 
Ratios of metabolite levels 
DOPAC/DA   0.57 ± 0.05 0.59 ± 0.04 0.58 ± 0.08 0.2 
HVA/DA   1.03 ± 0.17 1.37 ± 0.13 1.01 ± 0.13 0.95 
HIAA/5HT   3.83 ± 0.25 5.00 ± 0.71 3.75 ± 0.22 0.5 
ACh/Ch (x1000)   0.30 ± 0.03 0.34 ± 0.10 0.38 ± 0.10 0.83 
GABA/Glu (x1000)     32 ± 4     31 ± 3    35 ± 3 0.65 
___________________________________________________________________________ 
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Preliminary estimation using Western blotting (WB) suggested that the expression of 
dopamine biosynthesis enzyme tyrosine hydroxylase (TH) was lower (Fig. 1) but the decreases 
in other three enzymes of the catecholamine metabolic pathway: DOPA decarboxylase (DDC), 
catechol-O-methyltransferase (COMT) and dopamine--hydroxylase (DBH), were variable and 
the apparent differences did not reach statistical significance (Fig 1; see also the section on 
proteomics in control brains below).  
Expression of two other proteins potentially linked to dopamine and/or addiction 
mechanisms, namely DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) 
and CREB (cAMP response element-binding protein) were significantly decreased (Fig. 1) in 
alcoholic relative to control brains (Kashem et al., 2009, Pandey et al., 2004).  
Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum: Indolamines 
 Serotonin (5HT), HIAA and Tryp contents in alcoholic brains striatum were significantly 
decreased compared to the control brains striatum (Table 4; cf. also (Kashem et al., 2009, Pandey 
et al., 2004). The HIAA depletion in the alcoholic CN was higher (57%) relative to other regions 
(~ 38%; Table 4). Additionally, the expression of tryptophan hydroxylase (TPH), the key 
enzyme of serotonin biosynthesis, was decreased (44%) in the CN of AB (Fig 1, cf. also (Sun et 
al., 2012, Jacobsen et al., 2012). The increase in HIAA/5HT ratio was higher in the NAc (34%) 
than in the DS (Table 4). 
Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum: 
 Indolamines 
 Serotonin (5HT), HIAA and Tryp contents in alcoholic striatum were significantly decreased 
compared to the control brains striatum (Table 4; cf. also (Kashem et al., 2009, Pandey et al., 
2004). The HIAA depletion in the alcoholic CN was higher (57%) relative to other regions (~ 
38%; Table 4). Additionally, the expression of tryptophan hydroxylase (TPH), the key enzyme of 
serotonin biosynthesis, was decreased (44%) in the CN of alcoholic brains (Fig 1). The increase 
in HIAA/5HT ratio was higher in the NAc (34%) than in the DS (Table 4). 
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Table 4. Regional variations in alcohol-induced changes, expressed as % decrease (or † % increase) 
of metabolite levels in the regions of striatum 
--------------------------------------------------------------------------------------------------------------------------- 
____________________________________________________________________________________ 
The values are decreases or increases (in %) relative to the absolute values obtained in control brains and 
shown in Table 3. All decreases were statistically significant at P < 0.01 except for tyrosine and 
tryptophan where the statistical significance was at P < 0.05 level. Asterisks mark where the magnitudes 
of decrease/increase varied among regions (* P < 0.05, ** P < 0.01). 
Metabolites  Caudate  Putamen                N. Accumbens              P value 
_________________________________________________________________________________ 
DA  54.0 ± 4.2 62.4 ± 3.1 61.3 ± 7.9                      0.51 
DOPAC  47.1 ± 10.2 57.1 ± 6.7 36.8 ± 3.7                      0.188 
5HT 36.9 ± 9.1 44.3 ± 4.7 53.2 ± 2.7                      0.202 
NE  63.0 ± 7.0 41.5 ± 5.1 50.8 ± 4.9                      0.056 
HVA  41.9 ± 9.4 50.3 ± 9.1 47.5 ± 2.4                     0.7373 
HIAA  57.0 ± 3.7 36.5 ± 3.8 39.5 ± 4.5                     0.0056** 
Histamine            34.1 ± 8.4 28.7 ± 5.3 33.3 ± 9.0                     0.872 
Choline                24.8 ± 4.8 25.9 ± 5.1 13.5 ± 2.5                     0.11 
Acetylcholine       31.9 ± 7.4 34.8 ± 12.9 51.1 ± 6.5                     0.322 
Tryptophan  18.8 ± 7.5 19.3 ± 4.9 22.9 ± 4.5                     0.861 
Tyrosine  18.8 ± 8.8 20.3 ± 6.7 20.1 ± 5.1                     0.987 
Glutamate†        + 6.9 ± 1.7                          + 4.4 ± 0.8                   + 30.0 ± 9.0                     0.0068** 
GABA  14.7 ± 2.9 13.5 ± 2.7 15.5 ± 4.3                     0.911 
Glutathione  67.8 ± 5.5 34.7 ± 9.1  58.1 ± 6.8                    0.0163* 
----------------------------------------------------------------------------------------------------------------------------------
Changes in the ratios of metabolite levels 
DOPAC/DA†   + 17.1 ± 3.9                         + 19.8 ± 6.5                    + 76.4 ± 6.5                   0.0002** 
HVA/DA†        + 25.6 ± 5.8                          + 41.9 ±10.7                   + 52.3 ± 5.05                0.074 
HIAA/5HT†     +   9.3 ± 3.8                         + 14.4 ± 5.5                     + 34.1 ± 8.3                  0.0296* 
G_______________ABA/Glu          18.0 ± 5.4                           21.7 ± 7.1                         39.1 ± 6.3                   
0.070 
_________________________________________________________________________ 
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Legend for Figure 1.   
Total protein was extracted from the caudate nucleus of both control and alcoholic tissues and Western 
blotting (top) was performed using antibodies as specified in Materials and Methods.  Bands were 
digitized and quantified; the controls were normalized as 100 (bottom). Columns represent the mean ± SE 
(n = 3 per group; *significantly different from control at P < 0.05). 
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Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum:  
Acetylcholine   
Choline and acetylcholine contents were significantly decreased in alcoholic brains 
striatum (Table 4) and the degree of depletion appeared variable from one subregion to another 
but these variations did not reach statistical significance (Table 4).   
Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum:  
Amino Acids 
 No significant changes in GABA levels were observed between striata of alcoholic 
brains and control brains (Table 4).  Glu content was significantly higher in the VS (30%) 
relative to the DS (5%) (Table 4).  Glutamate decarboxylase (GAD), the enzyme of GABA 
synthesis, was lower in the CN of alcoholic brains (Fig. 1 and Table 5, see below).  
Changes in Neurotransmitter and Metabolite Levels in Alcoholic Striatum:  
Histamine  
Histamine (His) content was significantly lower in alcoholic brains and the rates of 
depletion were similar in all regions (Table 4). Preliminary estimations of histidine 
decarboxylase (HDC), an enzyme that synthesizes histamine, have indicated that its expression 
was not significantly decreased in AB (Fig. 1).  
Glutathione (GSH) 
 Free radical scavenging molecule GSH content was lower in alcoholic brains. The 
reduction was highest in CN (67%) followed by the NAc (58%) and P (34%) (Table 4). The only 
enzyme related to GSH that was found to be significantly decreased in the CN of alcoholic brains 
was glutathion-S-transferase Mu 3 (cf. the next section on proteomics and Table 5). 
Expression of proteins in the caudate nucleus studied by proteomics 
The average 2D-gels showed 570 spots in the samples from control brains and 550 spots in 
the samples of alcoholic brains. Subsequent analysis identified 25 unique proteins which were 
differentially expressed in the CN of alcoholic and control brains (Table 5). The proteins directly 
linked to DA included TH and COMT, an enzyme of catecholamine metabolism. One other 
protein linked to neurotransmitter metabolism, a GABA-synthesizing enzyme GAD65, was also 
decreased in the alcohol affected tissue. The decrease in TPH indicated by Westerb blotting 
studies was not, however, supported by the proteomics.   
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Changes in some of the proteins found to be differentially expressed in the CN of alcoholic 
and alcoholic brains could be related to oxidative stress, tissue damage and/or 
neurodegenerations (e.g. glutathione-S-transferase Mu 3, synaptosomal-assocaciated protein 25, 
amyloid-β-precursor protein-binding family B member 3, BH3-interacting domain death agonist 
BiD; Table 5).  
Table 5. Differentially expressed proteins in the alcoholic dorsal striatum relative to controls 
------------------------------------------------------------------------------------------------------------------------- 
Protein          Access. No. pI/mass (kDa)          MOWSE         Change 
              score 
_________________________________________________________________________________________ 
Tyrosine hydroxylase (TH)       P07101 5.90/59      78  - 3.67 
Pyridoxal phosphate phosphatase (PPPase)     Q96GD 6.12/32      80  - 2.06 
Catechol O-methyltransferase (COMT)     P21694 5.29/24      93  - 2.56 
Serine/threonine protein phophatases/ 
Protein phosphatase 1B     O75688 4.95/53     52    2.22 
Glia maturation factor beta     P60983 5.16/17     89  - 2.04 
Intermediate filament family orphan 1    Q0D215 4.83/63     33  - 5.06 
Glyoxalase domain-containing protein 2    A6NK44 6.08/17   137  - 2.19 
Lys-63-specific deubiquitinase BRCC36     P46736 5.59/37   152    1.10 
Synaptosomal-associated protein 25           Q53EM2 4.66/24     74  - 1.62 
Proactivator polypeptide      P07602 5.06/60     44    4.50 
Glutamate decarboxylase 2/GAD65     Q05329 6.45/65     61  - 3.28 
N-Acetylaspartyl-glutamate synthase A     Q81XN7 6.21/43     78    2.99 
GTPase NRas         P01111 5.01/21     72  - 3.43 
NF-kappa-B inhibitor beta       Q15653 4.70/38     23    2.81 
Guanine nucleotide-binding protein G(i)  
subunit alpha-2         P04899 5.34/30     76  - 1.80 
Protein-tyrosine phosphatase 1B        P18031 5.88/51     50    1.40 
Phosphoserine phosphatase        P78330 5.53/25     41  - 4.31 
Glutathione S-transferase Mu 3         P21266 5.37/27     68  - 1.50 
Beta-synuclein           Q16143 4.41/14     71  - 1.59 
Putative oncomodulin-2          P0CE71 4.11/12   127  - 1.52 
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Hippocalcin           Q5U068 4.96/23   120  - 2.08 
BH3-interacting domain death agonist (BiD)        P55957 5.27/22     85    2.20 
Transforming acidic coiled-coil-containing 
protein 1                       O75410 4.86/16     93  - 2.35 
Interferon alpha-1/1          P01562 5.32/22     67  - 1.49 
Amyloid beta A4 precursor  
protein-binding family B member 3               O95704 5.97/54     21    1.99 
________________________________________________________________________________ 
Tissue samples came from the caudate nucleus. The change is expressed as n-fold increase or (-) decrease. 
Accession number is for Swiss-Prot database, pI signifies the value of isoelectric point. MOWSE score, 
molecular weigth search score, a form of protein identification.  
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Discussion 
 
General 
To the best of author's knowledge, this is the first study using the LC-MS/MS technique 
to obtain information on the effects of long-term heavy alcohol intake on the levels of 
neurotransmitters and related metabolites in striatal regions of human brain. The major findings 
in this study are the following: First, lower levels of Tyr, Tryp, His, Ch, Ach, DA, 5HT, HVA, 
HIAA and GSH in alcoholic brains compared to control brains. Second, variation, in some cases, 
of the depletion rates from one part of striatum to another, suggests that neurotransmitter 
metabolism in the striatum does not have the same sensitivity to chronic alcohol in all subregions 
(Table 4). Third, the ratios of DOPAC/DA and HIAA/5HT were, in alcoholic brains higher in the 
VS relative to the DS. Thus it appears that both the VS and DS are sensitive to the effects of 
chronic alcohol intake. The susceptibility of DS to the chronic excessive alcohol intake is also in 
accordance with the observation of differences between alcoholi and control brain in terms of 
expression of several important proteins in the CN (a part of DS), as revealed by proteomics 
(Table 5) and WB (Fig. 1). 
 
Regional variations in the striatum of Control brains - differential sensitivity of DS and VS 
to alcohol: 
In control brains, Ch and Ach levels were higher and the NE level was lower in the NAc 
relative to the dorsal striatum suggesting that either the density of noradrenergic and cholinergic 
innervations, their synaptic activities or, simply the metabolic rate of Ch, Ach and NE in the VS 
differs from that in the DS. The above findings are compatible with other published data; for 
example a comparative study of cholinergic neurons in sub-regions of the striatum revealed that 
NAc has at least 30% more cholinergic neurons than the dorsal striatum (Meredith et al., 1989). 
The cholinergic interneurons of the VS have large dendritic arbors that connect many cell bodies 
including the core and shell subdivisions of the NAc. Cholinergic neurons have been shown to 
play an important role in the modulation of both food and drug intake including aversive 
responses to foods or drug-related addictive behaviours (Avena  and Rada, 2012, Morilak et al., 
2005). The stress-related neurotransmitter norepinephrine (NE) (Morilak et al., 2005) is lower in 
the VS relative to DS (Table 3).  
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The levels of catabolic products of DA and 5HT and their ratios in the DS did not differ 
significantly from those in NAc. This is consistent with the morphologic similarities of DS and 
the VS. Region-specific variable metabolite levels in the rat striatum have, however, been 
previously reported (Laplante et al., 2012, Schilman et al., 2010); it is, therefore, possible that 
more subtle differences will be revealed by future studies using larger numbers of human brains. 
In our earlier proteomic study it is noted that free radical scavenging (GSH metabolism) 
and pentose phosphate pathways were dominantly expressed in the splenium of corpus callosum 
(CC) relative to the genu of CC and, the higher activities of these two pathways might have been 
linked to the region-specific sensitivity to the alcohol.  Considering the present results in the 
context of the previous evidence and in analogy with previous conclusions, author propose that 
the neurochemistry of the NAc is different from that of DS in terms of alcohol-sensitivity of 
metabolic pathways associated with noradrenergic, dopaminergic and cholinergic 
neurotransmission and these differences may contribute to the pathophysiology of alcoholism 
and alcohol addiction (Dobbs  and Mark, 2012, Mark et al., 2011). 
 
Alcoholism-associated region-specific changes in neurotransmitter metabolism  
Previous studies have preferred NAc as the striatal region most important for the 
mechanisms of addictive behaviour, however there are indications that the DS may also be 
involved in addiction-related mechanisms (Volkow et al., 2003, Porrino et al., 2004, Volkow et 
al., 2004) even if this may involve its connections to VS (Nummenmaa et al., 2012). 
Specifically, alleviation of alcohol and nicotine addiction after a cerebrovascular incident in the 
human the DS has been reported (Muskens  et al., 2012). In the present study author has noted 
that the contents of most of the neurometabolites in the DS and theVS are similar (Table 3) but 
alcohol-induced expression patterns, in particular the relative changes (Table 4), in alcoholic 
regions (CN, P and NAc) are more variable. These results are reminiscent of those of Tran-
Nguyen et al (Tran-Nguyen et al., 1996) who found that the administration of the dopamine-
depleting toxin 6-hydroxydopamine into the DS and the VS produced a heterogeneous response 
in terms of changes in monoamine content in the regions.   
Thus DA in the DS might be involved in the addiction-related process analogous to that 
which exists in NAc and it is possible that both parts of the striatum contribute to drug 
craving/relapse and/or habitual learning involved in substance abuse (Everitt and Robbins, 2013, 
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Lee et al., 2013, Natori, et al., 2009). This suggestion is strongly supported by the differences 
between alcoholic and control brains identified by proteomics in the CN (a part of DS), 
particularly the reduced expression of DA-related proteins (Table 5). 
Glu content in alcoholic brains compared to control brains was significantly increased in 
NAc (30%) relative to DS (Table 4). This is in contrast to the other signalling molecules but 
similar findings have been made before; Glu level has been reported as increased in the 
prefrontal cortex of alcoholic patients relative to control and glutamate/glutamine ratio has been 
proposed as a biomarker for alcohol-dependence (Hermann et al., 2012, Koob, 2013). L-
Glutamate is the principal excitatory neurotransmitter in the mammalian CNS and, as such, 
would be expected to play the central role in a whole spectrum of brain functions (Bennett and 
Balcar, 1999, Sery et al., 2015). While short term exposure to alcohol decreases glu activity, long 
term exposure has the opposite effect (Koob, 2013, Valenzuela, 1997).  
 
Alcohol and oxidative stress 
Alcohol has been shown to induce oxidative stress and result in low levels of GSH in the 
brain cells; in fact, oxidative stress may be one of the most important mechanisms mediating 
alcohol-induced brain damage. It is, therefore, quite significant that, in this study auhtor 
observed that glutathione, the free radical scavenging molecule, was reduced by up to 60% in 
alcoholic tissues (Table 4). This is similar to the reductions in GSH reported by others (Lee et al., 
2014). The depletion of glutathione (GSH) would seem to correlate with alcohol-induced 
reduction in glutathione biosynthesis enzymes as detected previously in author's proteome 
studies in alcoholic post-mortem human and rat brain (Kashem, et al., 2007, Kashem, et al., 
2008, Kashem, et al., 2009a ); cf. decrease in glutathione S-transferase Mu 3 in the alcoholic CN 
in the present study (Table 5). In this context, the decreases in synaptosomal-associated protein 
25 and β-synuclein (Table 5) may indicate loss of synaptic contacts and the increase in 
apoptosis-associated protein BiD (Table 5) might indicate apoptotic loss of neurons caused by 
oxidative stress. The apparent regional variation in the effect of alcohol on GSH levels (Table 4) 
merits additional study.  
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Alcohol Induced Alteration of Neurotransmitter Biosynthesis Pathways 
The regionally-variable elevations of Glu content (but no clear change in the content of 
GABA) as observed in alcoholic brains relative to the control brains are of potential interest, 
given that a significant component of the ethanol effect on brain metabolism is exerted through a 
subtype of GABA(A) receptor (Rae et al., 2014) or by NMDA receptors (for a review see 
(Spanagel., 2009). GABA is synthesized from glutamate via pyridoxal 5'-phosphate dependent 
glutamic acid decarboxylase (L-glutamate-carboxy-1-lyase, EC 4.1.1.15; GAD). The deficiency 
of GABA would be consistent with low level of GAD (McBride et al., 1990) and/or deficit of its 
cofactor (Kashem et al., 2012).  
 In fact, even when the data in Table 4 were analysed by ANOVA over six independent 
data groups i.e. including three regions of control striatum and three regions of alcohol-affected 
striatum, the decreases were not statistically significant at P = 0.05 (not shown). GABA/Glu ratio 
in alcoholic relative to control brain might appear regionally variable; it is 39% in the VS 
compared to ~ 19% in the DS (Table 4) but, again, these variations were not statistically 
significant. Proteomics data show reduced expression of GAD65 in the alcoholic CN (a part of 
DS) compared to the control but this may not be enough to cause a significant deficiency in 
GABAergic inhibitory system (no significant difference detected by WB; Fig. 1).   
Alcohol and histamine are metabolized through a common enzymatic pathway (aldehyde 
reductase) and administration of ethanol has been shown to decrease His concentration in mice 
(Brabant et al., 2010); the present findings could be a result of reduced expression of His 
biosynthesis enzymes HDC (Fig. 1).  
Serotonin precursor amino acid Tyr, serotonin, 5HIAA and serotonin metabolic key 
enzymes tryptophan hydroxylase (TPH) and DDC have all been reported as decreased in 
alcoholic tissues (McBride et al., 1990, Vilpoux et al., 2009) indicating that long-term alcohol 
intake could suppress serotonin biosynthesis. Transgenic mice (TPH–2 deficient) displayed 60–
80% lower 5HT and increased capacity of ethanol consumption (Jacobsen et al., 2012). Other 
studies have shown that reduced levels of brain 5HT are associated with increased ethanol intake 
in both rodents and primates (Sachs et.al., 2014, Higley et al., 1996, Murphy et al., 1982). It has 
been proposed that 5HT deficiency (e.g., reduced levels of the 5HT metabolite, 5-HIAA) be used 
as a biomarker of alcoholism (Sachs et al., 2014, Borg et al., 1985).  
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Dysregulation of catecholaminergic system has been reported in alcoholism (Kohnke et 
al., 2002). In the present study we observed that DA and its precursor amino acid Tyr and 
catabolic products, NE, DOPAC and HVA content were all decreased in regions of alcoholic 
brains relative to their respective controls (Kashem et al., 2012, Sun et al., 2012, Rothblat et al., 
2001); these results suggested that alcohol either disturbed and/or damaged DA innervations 
leading to reduced biosynthesis. If the lower content of DA is caused by higher catabolism, then 
the alcoholic tissues might be expected to show higher levels of DOPAC, NE and HVA but this 
has turned out not to be the case in the present study, their contents were actually lower in the 
alcoholic regions. Moreover, the preliminary data have not shown any statistically significant 
changes in the two most important catecholamine catabolising enzymes: catechol-O-
methyltransferase and dopamine-β-hydroxylase (DBH);(Fig. 1), while more comprehensive 2D-
gel proteomic actually indicated reduced expression of COMT in alcoholic brains, at least in the 
CN (Table 5)  Genetic studies of human populations indicated that both high- and low- activity 
COMT alleles could be associated with alcoholism and the enzyme could also be regulated 
epigenetically (Sery et al., 2006, Voisey et al., 2011, Wang et al., 2001). Thus, the reasons for 
the decreases in the content of NE, DOPAC and HVA in alcoholic tissues could be caused by 
lower availability of the precursor molecule DA or it might be a result of deficient of 
biosynthesis. 
Expression of DA biosynthesising enzymes and proteins associated with DA signalling 
[TH, pyrophosphate phosphatase (PPP), DARPP-32] have been found altered in the striatum of a 
beer-drinking rat model of alcoholism (Kashem et al., 2012,  McBride et al., 2009) and this 
seems consistent with the decreased expressions of DARPP-32 indicated by the present study 
(Weinshenker et al., 2000, McPherson  and Lawrence, 2007).  
It is interesting to note that the preliminary WB quantification also indicated a decrease in 
the expression of CREB in the alcoholic  tissue. CREB regulates expression of many proteins in 
brain including TH, TPH, GAD, choline acetyl transferase, DBH, adenylyl cyclase and 
glutamine synthase (GS) (Asanuma et al., 1996, Lonze  and Ginty, 2002). Given that CREB 
activity is regulated by multiple phosphorylations and its immunological estimations may require 
special care (Platenik et al., 2005), the present finding would seem to be worth of a more 
thorough study using a larger sample.  
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\Concluding Remarks 
The present study has identified significant changes in neurotransmitter levels in all 
regions of striatum in alcoholic brain. There are significant decreases in the levels of several 
neurotransmitters (dopamine, noradrenaline and acetylcholine) and related metabolites. This is 
accompanied by similar changes in enzymes (at least in the caudate nucelus) involved in the 
neurotransmitter metabolism. Additionally, there is a significant decrease in the levels of 
antioxidant agent glutathione in all parts of striatum in alcoholic brains. This may further 
exacerbate the harmful effects of chronic heavy alcohol intake on brain tissue. Author has also 
identified changes to several proteins not directly related to the function and metabolism of 
neurotransmitters; these may reflect more general aspects of the damage caused by long-term 
heavy drinking and should be investigated in greater detail in more extensive studies. Despite a 
small number of brains used in the present study (and the protein data limited to the dorsal 
striatum only), the findings may add to a more comprehensive model of how alcohol and 
alcoholism affect neurotransmitter signalling in striatum and lay more solid foundation for the 
understanding of the relationship between alcohol addiction and alcohol-related disorders. 
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CHAPTER 3 
 
Exposure of rat neural stem cells to ethanol affects cell numbers and 
alters expression of 28 proteins 
 
(This chapter is based on paper accepted for publication in Neurochemical Research 
(Kashem et al., 2018. Neurochem Res. In Press). 
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Abstract 
 
Rat embryonic neural stem cells (rNSC) were exposed to ethanol (25 to 100 mM) for up to 96 hours. 
Ethanol induced oxidative stress and the cell numbers were lower at 50 and 100 mM ethanol with neuron-
like (MAP2-positive) cells particularly affected. Proteomics revealed 28 proteins as altered by ethanol. 
Some were constituents of cytoskeleton, others were involved in transcription/translation, signal 
transduction and oxidative stress. Nucleophosmin (NPM1) and dead-end protein homolog 1 (DND1) were 
further studied by immunocytochemical techniques in cultured neuron and astrocytes. In the case of 
DND1 (but not NPM1) ethanol induced similar changes in both types of cells. Given the critical role of 
the protein NPM1 in cell proliferation and differentiation, its reduced expression in ethanol-exposed 
rNSC could explain the lower cells numbers. However, considering the known effects of ethanol on brain 
tissue, comparison of the present findings with data on the effects of the anaesthetics sevoflurane, 
propofol and ketamine on stem cells, as available in the literature, suggests that ethanol may be cytotoxic 
to rNSC by activating GABA(A) receptors and inhibiting NMDA receptors. Thus the ethanol exposure 
may profoundly alter protein composition and functioning - including proliferation and survival - of 
rNSC, resulting in abnormalities which, if translated to humans, could contribute to the molecular and 
cellular mechanisms underlying the foetal alcohol spectrum disorder and/or alcoholism later in life.   
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Introduction 
 
Development and maturation of brain tissue includes both pre- and postnatal neurogenesis (Giedd 
et al., 1999, Anderson et al., 2000, Anderson et al., 1993). The rate of neurogenesis varies as a function of 
brain maturity (Dennis et al., 2006) but may also be influenced by anxiety, depression as well as by drug 
and alcohol intake (Cowen et al., 2008).  
Neural stem cells (NSC) can generate neuron, astrocytes and oligodendrocytes in the central 
nervous system (CNS; (McKay, 1997). NSC first migrate to form specific brain regions while, later in the 
life, during the process of adult neurogenesis, may respond to functional demands or serve as a 
replacement for damaged cells (Imitola et al., 2004). The normal cell generation may become 
compromised if the damage to the tissue is too great or the initial insult continues such as in an ongoing 
stress. The latter would include chronic drug use and alcoholism and, indeed, animal models have 
demonstrated that alcohol is toxic to the neuron-generating regions in brain (Geil et al., 2014). Even the 
blood ethanol levels not exceeding 330 mg/dl (app. 72 mM) have been shown to decrease neurogenesis in 
adolescent rats (Nixon and Crews, 2002, Herrera et al, 2003). In this context, it is of interest to note that 
blood alcohol level in Indian-American (indigenous) mothers who gave birth to offspring with fetal 
alcohol syndrome (fetal alcohol spectrum disorder; FASD) was reported at 80 mM (Kvigne et al., 2012); 
it is known that 100 mM alcohol can significantly influence human neurogenesis (Louis et al., 2017). In 
another study, low to moderate doses [(0.095% (21 mM) to 0.18% (40 mM)] of ethanol were shown to 
reduce the number of new neuron by two thirds and significantly increased the rate of cell death in the 
dentate gyrus (Herrera et al., 2003). Administration of ethanol to 35–40 days old rats indicated that the 
neurogenesis in the adolescent brain is particularly sensitive to ethanol (Crews et al., 2006, Redila et al., 
2006). Moreover, prenatal exposure to ethanol may further compromise postnatal neurogenesis and this 
may have an additional impact on mental health later in life (Redila et al., 2006, Klintsova et al., 2007). 
Production of neuron proceeds in four stages; proliferation of NSC, differentiation, migration and 
selective neuronal death/survival. Certain proportion of cells will succumb to programmed cell death 
(apoptosis); this is an integral part of the differentiation process and may accompany even adult 
neurogenesis. Ethanol interferes mainly at stages one and four (Teteno et al., 2006, Campbell et al., 
2014); it inhibits NSC proliferation and increases the cell death. Longer exposures (a four-day binge 
model) result in reduced cell proliferation and impaired survival (Morris, et al., 2010). Moreover, ethanol 
at 50 mM concentration can affect both the proliferation of NSC and gliogenesis (glial phenotype); 
ethanol can alter intrinsic cellular mechanisms of NSC, eventually impacting on the structural and 
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functional characteristics of both neuron and glial cells  (Vemuri et al., 2005). Such changes occur in 
prefrontal cortex, nucleus accumbens, and striatum (MacDonald and Roskams, 2009, Witt, 2010) thus 
potentially contributing to alcohol-induced functional deficits in those regions (Liyanage et al., 2014, 
Stragier, et al., 2015, Bonnaud  et al., 2016). 
Protein composition is of key importance to the understanding of normal cellular functions and 
their changes in disease. The technique of proteomics can thus serve as a convenient indicator of the state 
of health of a biological system. Specifically, proteomic analyses of human brain tissue have identified 
changes in 238 proteins as associated with alcoholic disorders (Kashem et al., 2007, Matsuda-Matsumoto, 
2007, Matsumoto et al., 2007, Kashem et al., 2008, Kashem et al., 2009a,Kashem et al., 2012, Kashem et 
al., 2016).  
Proteomic analysis of human neural stem cells (hNSC) detected thousands of proteins at the 
differentiation stage (review: vanHoof et al., 2012) but little is known how this proteom is influenced by 
ethanol. The aim of the present study was to investigate in vitro changes in the proteome of rat embryonic 
neural stem cells (rNSC) following a chronic exposure to the concentrations of alcohol which could be 
encoutered in vivo during heavy (or very heavy) drinking. Firstly, we looked at whether ethanol applied 
for 96 hours at concentrations 25, 50 and 100 mM can influence the numbers of cultured rNSC and 
whether such changes are accompanied by an increased lipid peroxidation indicating the presence of 
oxidative stress. Secondly, we used a proteomic approach to study the protein composition of rNSC 
exposed to 50 mM ethanol for 96 hours. Four of the proteins found to be significantly changed (two 
increased and two decreased) by the exposure to ethanol were estimated by Western blotting to verify the 
validity of the proteomic analysis. Additionally, two of the proteins strongly affected by the ethanol 
exposure (nucleophosmin; NPM1 and dead end homolog1; DND1; both classified as “nuclear proteins” 
and therefore deemed as potentially involved in the regulation of protein synthesis as well as cell 
proliferation and cell survival were selected for further studies by both Western blotting and 
immunocytochemistry, using primary cultures of neuron and astrocytes derived from rat brains. 
The data we present may contribute to a better understanding of how heavy alcohol drinking 
(particularly during pregnancy) alters the brain structure and function. 
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Materials and Methods 
Neural stem cell culture 
Rat neural stem cells (rNSC) were prepared from 14-day-old (E14) rat embryos as described 
earlier (Tateno, et al., 2006, Kashem et al., 2009). Animal experimental procedures were approved by the 
University of Sydney Animal Ethics Committee (AEC Protocol Number: 2013/5742). The telencephalon 
was separated and blood vessels and meningae were removed while the tissue was submerged in ice-cold 
Hank’s balanced salt solution (HBSS; Invitrogen, CA USA). After sectioning, the telencephalon tissue 
was incubated with 0.05% trypsin solution for 30 min, triturated with a glass pipette and filtered through 
70 µm nylon cell strainer (Falcon, USA). The resulting cell suspension was centrifuged (300 g for 5 
minutes at 4°C). The viability of the cells in the pellet was assessed by trypan blue (Invitrogen). The cells 
were seeded in complete neurobasal medium [(NBM, Invitrogen) + 2% B27 supplement (Invitrogen), + 
0.5 mM L-glutamine + 20 ng/ml recombinant human fibroblast growth factor 2 (FGF-2) + 20 ng/ml 
recombinant human epidermal growth factor (EGF, Life Tech)] at a density of 1 x 106 cells per mL in 
culture dishes coated with poly-L-ornithine (Sigma). The dishes were maintained for a week at 37oC in a 
5% CO2 atmosphere. For differentiation, the cells were washed and cultured in differentiating media (all 
components of complete neurobasal media except FGF-2 and EGF).  
Neuron and astrocytes  
The cortex tissue was obtained at the embryonic age (E) of either E15 (neuron) or E20 
(astrocytes) and treated as above. Following recommendations by available culture protocols (e.g. 
https://www.thermofisher.com/au/en/home/references/protocols/cell-culture) the cells were cultured 
either in neurobasal medium (NBM, Invitrogen) + 2% B27 supplement (Invitrogen), + 0.5 mM L-
glutamine with antibiotics (neuron) or in serum/antibiotics containing DMEM/F-12 (astrocytes) for 2 
weeks at 37°C in humidified 5% CO2/95% air conditions. While most of the protocols usually 
recommend brain tissue harvested at embryonic ages E17 or E18 for the neuronal cultures and brains 
from later embryonic stages or neonatal rats for the preparation of astrocytic cultures (Hansson, 1984) we 
used E15 for the neuronal cultures (cf. also (Dichter, 1978) and E20 for the astrocytic culture with 
satisfactory results, as indicated both by the appearance of the cells and expression of the characteristic 
markers (Fig. 3 and 4). 
Ethanol treatment and sample collection 
The cultured cells were exposed to ethanol (0, 25, 50 and 100 mM) added directly to the 
differentiation neurobasal media. In order to reduce the loss of ethanol by evaporation (Rodriguez et al., 
1992), author used a closed system (closed 25 mL vessel) and changed the media every 24 hours 
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(Rodriguez et al., 1992, Eysseric et al., 1997). The ethanol exposure lasted for up to 96 hours. For 
proteomics, the cells were washed twice with ice-cold phosphate-buffered saline (PBS) and collected in 
200 μL solubilising buffer (7 M urea, 2 M thiourea, 1% C7bZO and 40 mM Tris-HCl, pH 10.4; Sigma). 
After sonication (3 times for 5 sec each) the samples were stored at -80°C (Kashem et al., 2009, Ahmed et 
al., 2012). 
Estimation of cell numbers and immunofluorescence 
Cells on coverslips were fixed with 4% paraformaldehyde for 15 min, followed by washing with 
PBS and exposure to 0.3% Triton-X100 for 5 min. After washing with PBS, the cells were incubated 
(blocked) with 5% normal horse serum for 1 hour, followed by anti-microtubule-associated-protein 2 
antibody (MAP2, mouse, 1:1000; Sigma) for 2 hours. The cells were further incubated in mouse IgG 
FITC labelling reagent (1:1000, Invitrogen) for 45 min and subsequently washed with PBS. Following the 
application of DAPI (for 10 min) cells were observed under Leica SPE2 confocal microscope (Leica 
Microsystem). The images were captured and the cells with DAPI-labelled nuclei were counted (about 
150 per image) using Image J software (manual option). Whole coverslip contained, typically 200 to 300 
cells or fewer in ethanol treated cultures. (cf. legend of Fig. 1 for further details).  
For immuno-histochemistry of neuron and astrocytes, the cells were fixed, treated with Triton X-
100 and blocked with horse serum as described above (immunofluorescence) and incubated with a 
mixture of neuron- or astrocyte-specific marker antibodies. For neuron, anti-microtubule-associated-
protein 2 (MAP2, mouse and rabbit, 1:1000; Sigma) was used as a marker while anti-glial fibrillary acidic 
protein (GFAP, mouse and rabbit, 1:1000; Sigma) was applied to label astrocytes. The cells were further 
incubated with anti-rabbit nucleophosmin (NPM1) or anti-mouse dead end protein homolog 1 (DND1; 
Santa Cruz Biotech, Australia) for 2 hours. Anti- rabbit and/or anti-mouse secondary antibodies 
conjugated with CF-568 and/or CF488 were treated for 45 min and then washed with PBS. The cells were 
observed under confocal microscope (Leica SPE2) and the intensity of the fluorescence was quantified by 
image J software (Shin et al., 2009, Nguyen et al., 2010). 
Lipid peroxidation assay 
 Acohol treated and untreated cells were homogenised in 0.5 mL of 1% KCl solution and 
supernatant was collected after centrifugation at 16,000 g x 10 min at 4 0C.  Aliquots of 0.25 mL of the 
homogenates were mixed with double volume (0.50 mL) of 15% acetic acid containing thiobarbituric acid 
(0.5% (Garcia et al., 2005). The mixture was heated to 95 0C for 15 min and, after cooling, centrifuged at 
5000 g x 5 min to remove any precipitated matter. The absorbance of the supernatant was measured at 
532 nm. The malondialdehyde concentration was calculated from the following formula: absorbance/1.56 
x 105; (where 1.56 x 105 M-1cm-1 is the malondialdehyde extinction coefficient). 
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Statistical analyses and presentation of data 
 Statistical evaluation of differences between alcohol-free (controls) and alcohol-treated cells was 
done by ANOVA (Tukey multiple comparison test). Both the statistics and the graphical representation of 
data (Figs. 1, 3 and 4) was done using GrapPad Prism software version 7.02 except for Fig 2 where 
BioRad software was used. For details see the figure legends. 
Proteomics 
The cells (exposed to ethanol for 96 hours; cf. the section on “Ethanol treatment and sample 
collection” above) were trypsinized, extracted with urea buffer (7 M urea, 2 M thiourea and 1% C7bZO 
and 40 mM tris-HCl) and the proteomics performed as detailed earlier (Kashe et al., 2007, Kashem et al., 
2008, Kashem et al., 2009a, Kashem et al., 2012, van Nieuwenhuijzen et al., 2010), Kashem et al., 2016). 
The extracted samples were pelleted at 16,000x g for 20 min at 15 C; the supernatant was reduced and 
alkylated with 5 mM tributyl phosphine and 10 mM acrylamide monomer at room temperature for 2 
hours. The reaction was quenched by 10 mM dithiothreitol (DTT). The citric acid was used to acidify the 
samples to approximately pH 5. The acetone-precipitated pellets were air dried and resuspended in 0.3 
mL of buffer consisting of 7 M urea, 2 M thiourea and 1% C7bZO. The final extracts were stored at -80 
C before isoelectric focusing. 
The protein was quantified (Bradford, 1976) using BSA (Sigma-Aldrich, Castle Hill, NSW, 
Australia) as a standard. Details of isoelectric focusing, electrophoresis and staining have been published 
Kashe et al., 2007, Kashem et al., 2008, Kashem et al., 2009b, Kashem et al., 2012, van Nieuwenhuijzen 
et al., 2010), Kashem et al., 2016).  A total of 12 gels (duplicates for each sample, n=3) were scanned 
using a flatbed scanner (UMAX). The images were analysed by Phoretix 2D Expression software 
(Nonlinear). Averaged gels were created for each alcohol treated/control group and averaging parameters 
were set at 70%. Protein spots were evaluated as volumes (spot area x optical density) with the image 
analysis software and compared between groups with statistical analysis (ANOVA, P<0.05). The false 
discovery rate (FDR) was calculated as described by Storey (Storey and Tibshirani, 2003). The protein 
spots of interest were cut from the gel, de-stained using 25 mM NHHCO3/50% (v/v) acetonitrile (ACN) 
for 3 min  15 min at 37 C and digested with 12.5 ng/mL trypsin (Roche, sequencing grade), The 
peptides were purified using C-18 purification tips (Eppendorf). Matrix (5 mg/mL solution of -cyano-4-
hydroxycinnamic acid in 70% (v/v) ACN/0.1% (v/v) TFA) mixed samples were analysed by Qstar XL 
Excll Hybride MS system (AB Applied Biosystems) in positive reflector mode, with delayed extraction. 
The spectra from MALDI-TOF were searched against the Swissprot protein databases using the 
MASCOT search engine (http://www.matrixscience.com/). Positive protein identification was performed 
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based on a MOWSE score (> 54, rattus database) with matched isoelectric pH (pI) and molecular weight 
(MW) values (estimated from 2D gels) and sequence coverage. 
 
Western blot analysis 
Alcohol treated (96 h) brain cells were collected (n=3) and protein was extracted by previous 
described techniques (Kashem et al., 2012). Western blot analysis was performed as described previously 
(Kashem et al., 2009b, Kashem et al., 2012, Kashem et al., 2016). Protein separated (20 g) by SDS-
PAGE were transferred to PVDF (polyvinylidene difluoride) membranes (Kashem et al., 2009) blocked 
with 5% skim milk and incubated with primary antibodies [(NPM, DND1, heat shock protein, 
heterogeneous nuclear ribonucleoproteins-C (hnRNP-C), enolase and synaptosome associated protein-29 
(SNAP)] solution. Secondary antibodies (anti-mouse and anti-rabbit IgG, Sigma) were added and the 
spots were visualized using an ECL (enhanced chemiluminescence) full spell system (GE Healthcare, 
Australia). The intensity of the spots was quantified by Biorad software (Bio-Rad, Sydney, Australia). 
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Results 
 
Exposure (96 hours) to the lowest ethanol concentration (25 mM) had no significant (P > 0.05) impact on 
either cell numbers or morphology but the higher concentrations (50 or 100 mM) reduced cell growth (Fig 
1a). MAP-2 positive cells appeared to be reduced in numbers at 50 and 100 mM ethanol relative to 
control (Fig 1a). The reduction in cell numbers was quantified by counting the cell nuclei stained by 
DAPI. DAPI-positive cells were reduced in numbers by 38% and 52% (P < 0.05) at 50 and 100 mM 
ethanol relative to control (Fig. 1b). Lipid peroxidation analysis (Fig. 1b) revealed that the exposure of the 
cells to ethanol induced oxidative stress compared to controls (at 50 mM about 1.6-fold and at 100 mM 
about 2.1-fold).  
 
 
 
Fig. 1.  Immunofluorogenic visualization of rat neural stem cells treated with various concentration of 
alcohol at 96 h of incubation (a). Fig.1a is MAP-2 positive cells growth.  Fig.1b shows the numbers of 
DAPI stained nuclei and the extent of lipid peroxidation in the cells after 96 hours of ethanol exposure. 
The scales are in arbitrary units and the columns are means ± SD (n = 3). The data were analysed by 
ANOVA (Tukey multiple comparison test) and found significantly different from control (0 mM ethanol) 
at * P < 0.05, ** P < 0.01 and *** P < 0.001.   
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In the proteomics, typical 2-DE gels displayed 550 spots (six gels from controls and six gels from 
ethanol-treated samples) and more than 92% of all spots were matched across the two groups. Analysis 
revealed that 40 protein spots were differentially expressed in ethanol-exposed cells relative to the 
ethanol-free controls (P < 0.05; ANOVA); 17 protein spots (~ 43%) showing an increased expression 
while the remainder were decreased. From the differentially expressed protein spots, author has positively 
identified 28 proteins using MALDI-TOF (Table 1) while the remaining ones were not identifiable 
because of low expression of proteins. Functionally, the identified proteins could be classified as 
structural (two proteins, ~ 7%), intracellular metabolism (six proteins, ~ 21%), nuclear (seven proteins, ~ 
25%), related to oxidative stress (six proteins, ~ 21%), signal transduction (four proteins, ~ 14%) and no 
specific class (three proteins, ~ 11%). Among the identified proteins, nine were increased (including two 
out of six metabolic, three out of seven nuclear and three out of six oxidative stress-related proteins) while 
the remaining ones were decreased (including both structural, four out of six metabolic, four out of seven 
nuclear, three out of six oxidative stress-related and all four signalling proteins). 
 Heat shock protein (HSP), synaptosomal associated protein-29 (SNAP-29), enolase (α) and 
heterogeneous nuclear ribonucleoprotein C (hnRNP C) which were altered in ethanol-exposed rNSC 
(Table 1) were assessed by Western blotting (Fig 2). These analyses did not contradict the outcomes of 
the estimations obtained by the proteomic studies (Table 1) and were not pursued further. Nucleolar 
phosphoprotein (nucleophosmin, NPM1) and dead end homolog1 (DND1) which were selected for 
immunocytochemical analyses in cultured neurons and astrocytes were also estimated by Western blotting 
in those preparations (Fig 3 and Fig 4). 
Immunofluorescence indicated somewhat higher expressions of NPM1 at 25 mM ethanol, 
especially in neuron (cf. also Western blotting in Fig 3d and 3f), but a lower expression in astrocytes 
exposed to 100 mM ethanol (Fig. 3e). The immunofluorescence was detected particularly over the nuclear 
area though author also noticed the NPM staining in cytosolic area at the lowest concentration (25 mM) 
of ethanol (Fig. 3c).  
In the case of DND1, immunocytochemical analysis revealed that the expression significantly 
increased both in neuron and astrocytes at 25, 50 and 100 mM ethanol (Fig 4). Western blotting was 
consistent with the immunocytochemistry, indicating that DND1 protein expression increased in both 
neuron and astrocytes at the higher (50 and 100 mM) concentration of ethanol (Fig 4). 
60 
 
 
Fig 2 Total protein was extracted from the neural stem cells from both control and 50 mM alcohol-
exposed cells and western blotting was performed on selected proteins identified as altered by alcohol-
exposure by proteomics. MAP-2 was used as an internal control. Bands were digitized and evaluated by 
Bio-Rad software. Fig 2b represents average values of two bands. 
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Fig. 3 Immunocytochemical visualization of the expression of NPM1 in neuron (a) and astrocytes (c) 
exposed to various concentrations of alcohol for 96 hours. The green colour of the Fig 3a is MAP-2 and 
red colour is NPM1 protein; in astrocytes (c), green is NPM1 and red is GFAP. Intensity of fluorescence 
was estimated for 9 or 10 cells by Image J software (e). The scales (e) are in arbitrary units and the 
columns are means ± SD (n = 9-10). The data were analysed by ANOVA (Tukey multiple comparison 
test) and those significantly different from control (0 mM ethanol) are marked by asterisks as ** P < 0.01 
and *** P < 0.001. Total protein was extracted from cells exposed to 50 mM alcohol for 96 h and 
subjected to western blotting using an antibody against NPM1 protein (neurons: b, astrocytes: d). Bands 
were analysed by Bio-rad software; Fig 3f shows average of the two bands shown in b and d, normalized 
so as the control (0 mM ethanol) equals 100. 
 
 
 
 
 
 
 
 
 
62 
 
 
Fig. 4. Immunocytochemical visualization of the expression of DND1 in neuron (a) and astrocytes (c) 
exposed to various concentrations of alcohol for 96 hours. The green colour of the Fig 4a is MAP2 and 
red colour is DND1 protein; in astrocytes, green is DND1 and red is GFAP. Intensity of fluorescence was 
estimated for 10 or 11 cells by Image J software (e). The scales (e) are in arbitrary units and the columns 
are means ± SD (n = 10-11). Total protein was extracted from cells exposed to 50 mM alcohol for 96 h 
and subjected to western blotting using an antibody against DND1 protein (neurons: b, astrocytes: d). 
Bands were analysed by Bio-rad software. 
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Table 1. Alcohol induced differential expression of proteins in rNSC exposed to 50 mM ethanol 
for 96 h. 
Protein 
Class 
Fold change  
(p/q values) 
Accession 
no 
PI/Mass 
(kDA) 
Protein Name  Function 
Structural 
Protein  
-1.68  
(0.048/0.095) 
P47942 5.95/62 Dihydropyrimidinase 
related protein-2 
(DRP-2) 
Involves neural development, 
polarity, axon growth and guidance, 
migration and remodelling of the 
cytoskeleton.  -1.56 
(0.028/0.065) 
Q62952 5.96/62 DRP-3 
Metabolic 
protein 
 
 
 
 
 
 
 
 
 
 
 
-2.98 
(0.018/0.025) 
P04764 5.0/47 Enolase (α) Glycolytic enzyme works as marker 
of stress in cellular system. 
-1.98 
(0.024/0.045) 
Q02589 5.5/40 ADP-ribosylarginine 
hydrolase 
Regulates G1-S phase of cell cycle 
and regulates DNA stability. 
-1.76 
(0.0161/0.027) 
Q68FS2 5.4/46 COP9 signalosome 
complex subunit 4 
Involves in various cellular & 
developmental processes including 
signalling. 
2.88 
(0.0032/0.026) 
P54921 5.04/40 Soluble NSF 
attachment protein 
(α) 
Required for vesicular transport 
between the endoplasmic reticulum 
and the Golgi apparatus 
5.92 
(0.0012/0.016) 
Q9JI56 4.66/29 SNAP-29 protein 
(synaptosomal 
associated protein-
29) 
The protein encoded by this gene 
binds tightly to multiple syntaxins 
and is localized in intracellular 
plasma membrane. 
-1.88 
(0.0014/0.022) 
Q8VHK7 5.2/26 Hepatoma-derived 
growth factor 
Heparin-binding protein, with 
mitogenic activity for fibroblasts. 
Acts as a transcriptional repressor 
and involves in proliferation, 
angiogenic, and neurotrophic 
activity. 
Nuclear 
protein 
-1.68 
(0.0022/0.036) 
P13084 5.1/32 Nucleolar 
phosphoprotein 
(nucleophosmin, 
NPM-1 or B-23) 
Involved in diverse cellular 
processes such as ribosome 
biogenesis, centrosome duplication, 
protein chaperoning, histone 
assembly, cell proliferation, and 
regulation of p21/p53. 
1.75 
(0.0033/0.046) 
Q8IYX4 6.9/38 Dead end homolog 
protein 1 
RNA-binding protein that positively 
regulates gene expression by 
prohibiting miRNA-mediated gene 
suppression.  
-3.74 
(0.0024/0.039) 
Q8VHV7 5.32/45 Heterogeneous 
nuclear 
ribonucleoprotein H 
 These proteins are associated with 
pre-mRNAs in the nucleus and 
appear to influence pre-mRNA 
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-2.69 
(0.0032/0.026) 
P07910 5.4/33 Heterogeneous 
nuclear 
ribonucleoprotein C 
processing and other aspects of 
mRNA metabolism and transport. 
hnRNP C heavily involved in the 
alternative splicig mechanisms 
-2.70 
(0.0327/0.081) 
Q63413 5.42/49 Spliceosome RNA 
helicase Bat-1 
Involved in nuclear export of 
spliced and unspliced mRNA. 
1.80 
(0.012/0.047) 
Q68FR9 5.02/35 Translation 
elongation factor-1 
(δ) 
Regulates induction of heat-shock-
responsive genes through 
association with heat shock 
transcription factors and direct 
DNA-binding at heat shock 
promoter elements   
1.53  
(0.042/0.067) 
Q3T1J1 5.12/16 Translation initiation 
factor 5A-1  
Involve in cell proliferation and 
regulation of apoptosis. 
 
Oxidative 
stress 
3.5  
(0.01/0.04) 
P34058 5.37/90 Heat shock protein 
(HSP-90) 
Molecular chaperone, promotes   
maturation and maintenance the 
structure of the proteins and control 
signal transduction. 
 
 
4.44  
(0.012/0.047) 
P55063 5.3/70 Heat shock protein 
(HSP-70) 
1.88  
(0.016/0.037) 
P63039 5.23/60 Heat shock protein 
(HSP-60) 
-2.65 
(0.0079/0.042) 
Q6AXV9 6.14/25 Glutathione S 
transferase 
Exhibits glutathione-dependent thiol 
transferase activity 
-1.68 
(0.002/0.0205) 
P28480 5.8/60 T-complex protein 1 
subunit 
Molecular chaperone; assists the 
folding of proteins upon ATP 
hydrolysis.  
1.63 
(0.007/0.040) 
Q5VLR5  BWK4 Cell redox homeostasis 
Signalling 
protein 
-1.68 
(0.0015/0.029) 
P62138 4.95/53 Serine/threonine 
protein phosphatase 
(PP-1) 
PP-1 is essential for cell division, 
and regulates glycogen metabolism, 
and protein synthesis. It is 
associated with over 200 regulatory 
proteins and dephosphorylates 100 
of biological targets.  
-2.2 
(0.0012/0.0197) 
Q32PX6 6.9/21 Ras homolog gene 
family, member G 
GTPase activity 
-2.2  
(0.0013/ 0.018) 
P50399 5.5/50 RAB GDP 
dissociation inhibitor 
(β) 
Regulates the GDP/GTP exchange 
reaction of most Rab proteins by 
inhibiting the dissociation of GDP 
from them.  
65 
 
-1.82  
(0.0013/ 0.018) 
P50398 5.2/50 RAB GDP 
dissociation inhibitor 
(α) 
Regulates the GDP/GTP exchange 
reaction of most Rab proteins by 
inhibiting the dissociation of GDP 
from them.  
Not 
classified 
elsewhere 
1.91 
(0.001/0.0197) 
Q9GZS3 7.0/33 WD repeat-
containing protein 61 
Component of the polymerase 
associated factor and is implicated 
in regulation of development and 
maintenance of embryonic stem cell 
pluripotency. 
-1.86 
(0.007/ 0.0177) 
Q62952 5.95/61 Collapsin response 
mediator protein 4 
(CRMP-4) 
Plays a role in axon guidance, 
neuronal growth cone collapse and 
cell migration 
-1.49 
(0.0014/0.0247) 
Q5RKH6 5.5/75 Protein OS-9 May bind terminally misfolded non-
glycosylated proteins 
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Discussion 
Inhibition of glutamate NMDA receptors (Lovinger et al., 1990) and/or activation of a subtype of 
GABA receptors (Spanagel., 2009, Rae et al., 2014, Rae et al., 2014a) parallel immediate effects of 
alcohol-drinking and probably account for much of the short-term response and consequences (acute 
alcohol intoxication followed by “morning after”) (Davidson  et al., 1995, Hoffman, 1995). In contrast to 
the receptor-mediated acute effects, longer exposures to ethanol may trigger additional mechanisms 
leading to profound changes in the living cells and tissues. Apart from resulting in cytotoxicity, chronic 
alcohol can specifically influence protein synthesis and cell proliferation, particularly in the developing 
brain (Berg et al., 2013, Ming and Song, 2011). The present study reports changes in the protein 
composition of cells cultured from developing rat brain following a four-day exposure to high 
concentrations of ethanol.  
As author did not specifically investigate neural stem cell functions and properties; the “rNSC” 
culture represents, strictly speaking, merely a primary culture of fetal brain tissue at certain stage of 
development. However, the methodology that author used is known to produce > 95% NSC (Kashem et 
al., 2009) and the results in Fig. 1a are, therefore, consistent with significant cytotoxic effects of alcohol 
on the fetal rat brain-derived stem cells. This is further underscored by the increased lipid peroxidation in 
the presence of alcohol (Fig 1b). Lipid peroxidation has been used as a marker of oxidative stress 
associated with cytotoxicity in a range of brain cells and tissues (Stastny, et al., 2004, Garcia et al., 2008, 
Rangel-Lopez et al., 2015). Therefore, the current data suggest that oxidative damage is a potentially 
significant component of the ethanol-related cytotoxicity leading to the loss of cells cultured from 
embryonic (E15) rat brain tissue.  
Given that ethanol interferes with the NSC proliferation and increases the cell death (Tateno, et 
al., 2006, Campbell et al., 2004) the remainder of the following discussion will focus on proteins 
potentially involved in the cell proliferation/differentiation, oxidative stress and nucleus-associated 
mechanisms. 
Cell Proliferation and Differentiation 
Hepatoma-derived growth factor (HDGF) was significantly influenced by ethanol exposure. 
HDGF has been linked to hepatocellular carcinoma (HCC) as a multi-functional protein involved in cell 
proliferation, angiogenesis and anti-apoptosis (Enomoto et al., 2015). HDGF overexpression promotes the 
proliferation of HCC (Enomoto et al., 2015a) and/or gliomas (Zhang et al., 2012) while the reduction in 
HDGF expression inhibits the proliferation of HCC cells. Knocking down of nuclear HDGF expression in 
the cells of human glioblastoma multiformis induces apoptosis (Hsu et al., 2012). By analogy, the 
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decreased expression of HDGF in ethanol-exposed cells could explain lower proliferation rates of brain 
cells early in the development. 
Two isoforms of dihydropyrimidinase-related protein-2 and 3 (DRP-2 and DRP-3) were reported 
to be lower in ethanol-exposed cells (Alexander-Kaufman et al., 2006) The DRP family of proteins, also 
called the collapsin response mediator proteins (CRMP), has been implicated in the development of the 
CNS particularly in axon guidance and cell migration. Lower DRP-2 could, therefore, disturb neural 
development and plasticity (Nakata et al., 2003) and this is supported by reports of DRP-2 being 
decreased in other conditions involving abnormal development such as schizophrenia and Down's 
syndrome (Johnston-Wilson et al., 2000). Alternatively, the decreased DRP-2 levels could be a result of 
proteolysis activated by cytosolic Ca2+ increased by the ethanol-exposure (Luo, 2014); cf. also the effect 
of ethanol on Ca2+-permeable NMDA receptors (Davidson et al., 1995). 
ADP-ribosylarginine hydrolase (ADPRH) removes mono-ADP-ribose moieties from arginines in 
cellular proteins. Mutation in the ADPRH gene alters G1 stage of the cell-cycle and a reduced ADPRH in 
NSC exposed to ethanol could lead to altered G1-S phase thus decreasing the cell proliferation (Kato et 
al., 2011). 
NPM1, a nucleolar and nucleoplasma-localized protein (Grisendi  and Pandolfi, 2005, Qing et al., 
2008, Pfister and D’Mello, 2015), may bind to unduplicated centrosomes thus altering Cyclin 
E/CDK2 activity which, in turn, regulates G1/S transition (Okuda et al., 2000). NPM1 has been shown to 
foster survival of proliferating cells (Lindstrom, 2011, Box et al., 2016), therefore the lower cell 
proliferation in the present study may have been caused by the lower expression of NPM1 induced by 
ethanol and/or its metabolites (see also below in the section on “Nuclear Activities and Protein 
Synthesis”).  
Changes in Oxidative Stress Defence Pathways  
Ethanol may generate free radicals [review (Luo, 2014)] in vivo either through its metabolism 
(e.g. via the oxidation to aldehyde) or by interfering with radical scavenging systems. Indeed, long-term 
chronic ethanol induced lipid peroxidation and depleted GSH levels in human striatum (Kashem et al., 
2016). Reduced expression of glutathione transferase (GST) in the present study is also reminiscent of 
results obtained in human postmortem brain tissue of heavy drinkers (Kashem et al., 2007, Kashem et al., 
2008, Kashem et al., 2009, Kashem et al., 2012, Kashem et al., 2016). The ethanol-produced reactive 
oxygen species are eliminated by GST activity (Peter and Chiramel, 2013) and low expression of GST 
reduces the protection of neurons against oxidative insults. 
The glycolytic enzyme α-enolase also acts as a neurotrophic factor (Takei et al., 1991), a heat-
shock protein (HSP48) and a hypoxic stress protein (review: Diaz-Ramos et al., 2012).  Glycolytic 
enzymes including α-enolase are enriched in apoptotic cells and α-enolase deficit could compromise the 
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hypoxia tolerance (which may include nonglycolytic mechanisms (Diaz-Ramos  et al., 2012, 
Subramanian and Miller, 2000).   
Ethanol increases the presence of SNAP25 and SNARE complex (Fatemi et al., 2001, Tafoya et 
al., 2006) and these changes may indicate a defensive action against the effects of ethanol (Varodayan et 
al., 2011).  
Heat shock protein 70 (hsp70) expression is regulated by environmental stresses including 
ethanol exposure (Mandrekar et al., 2008, Gorini et al., 2013). Upregulations of hsp70 mRNA, hsp70 
protein and heat shock factor-1 (HSF1) have all been reported in the liver of mice exposed to acute 
ethanol (Varodayan et al., 2011, Gorini et al., 2013). Acute and chronic ethanol induces HSP genes such 
as hsp70, hsp90, and glucose-regulated protein 78 (GRP-78), via HSF-1 activation in neuronal cells 
(Tunici et al., 1999).  HSP contributes to cell survival via binding to other proteins thus preventing the 
protein misfolding (Borges and Ramos, 2005, Verghese et al., 2012).  
Nuclear Activities and Protein Synthesis 
The heterogeneous nuclear protein (hnRNP) corresponds to a family of multifunctional RNA-
binding nuclear proteins (review: Geuens et al., 2016). Two of these proteins, hnRNP H and hnRNP C 
were significantly reduced in the ethanol-exposed rNSC. The protein hnRNP H may be linked to human 
cancers while protein C of the hnRNP family is best known for its role in pre-mRNA alternative splicing 
(Geuens et al., 2016). Alternative splicing is of interest in alcoholism since the glutamate transporter 
EAAT1 (GLAST), reported as severely affected by chronic drinking (review: Sery et al., 2015) but see 
(Alshehri et al., 2017, Kryger and Wilce, 2010), exists in many alternate splicing forms (Lee and Pow, 
2010). EAAT1 (GLAST) is a key protein in glutamatergic neurotransmission which is known to be 
perturbed by ethanol (Spanagel, 2009); the conflicting data (Alshehri et al., 2017, Kryger and Wilce, 
2010,  Ramondini et al., 1992, Flatscher-Bader and Wilce, 2005) could be explained by a changed pattern 
of its alternate splicing in ethanol-affected tissue. The protein hnRNP C has been linked to breast cancer 
(Anantha et al., 2013) but, perhaps more importantly in the context of FASD, its abnormal expression has 
been associated with birth defects in mammals including humans (Zhang et al., 2008, Sari et al., 2010). 
“Helicase” is a group of enzymes which can unwind double helices of nucleic acids (Umate et al., 
2011). Spliceosome RNA helicase Ddx39b is involved in the nuclear export of mRNA and its reduced 
expression in ethanol-exposed cells could have a severe impact on the RNA translation (Schwer and 
Meszaros, 2000).    
The DND1 (increased by ethanol in both neuron and astrocytes, Fig 4) can block miRNA-
mediated gene suppression. DND1 plays a key role in the primordial germ cell (PGC) survival and 
migration (Kedde and Agami, 2008) and its defects also cause sperm sterility, inducing testicular germ 
cell tumours in mice (Youngren et al., 2005, Zhu et al., 2011). DND1 inactivation in mice leads to 
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sterility at birth stage (Bhattacharya et al., 2007). DND1 interacts with several mRNAs including mRNAs 
of both anti- and pro-apoptotic factors, BCLX and BAX, respectively. Transcripts of pluripotency factors, 
cell cycle regulators and apoptotic factors associated with DND1 have been reported in  DND1 
recombinant study in human embryonic stem cells (Zhu et al., 2011).  
Exposure to high concentrations of ethanol decreased NPM1 in rNSC and perturbed its 
expression in both neuron and astrocytes (Table 1, Fig 3). This might in part explain the lower cell 
numbers of the ethanol-exposed cells (Fig. 1) since NPM1 is involved in DNA replication, recombination, 
transcription and repair (Grisendi and Pandolfi, 2005, Colombo et al., 2005) as well as elsewhere 
(Okuwaki et al., 2001, Abe et al., 2018). This interpretation is also in agreement with reports that the 
knockout of NPM1 in mice leads to unrestricted centrosome duplication, genomic instability and 
impaired ribosome biogenesis (Grisendi and Pandolfi, 2005, Chiarella et al., 2013). In addition, NPM-
induced p21 expression activates gene transcription by de-repressing p300–CREBBP (CREB-binding 
protein; (Lill et al., 1997, Kasper et al., 2011)) and can regulate p53-mediated apoptosis under the 
conditions of cellular stress (Abbas and Dutta, 2009). Thus, the normal level of NPM1 expression could 
very well be a critical factor in determining the healthy proliferation and differentiation of the NSC (cf. 
also above under “Cell Proliferation and Differentiation”).   
Summary and concluding statements 
The main finding of the study is the large extent of changes in the expression of proteins in 
cultured embryonic cells (including neural stem cells) exposed to alcohol. Altered expression of so many 
proteins that are crucial for the normal cell proliferation and survival, should it occur following a similar 
exposure to alcohol in vivo, would not be without profound consequences for brain development. 
More specifically, the present study resulted in the first observation of changes in DND1 and 
NPM1 expressions linked to ethanol exposure. Given the roles of NPM1 in cell proliferation, the lower 
expression of NPM1 could, in part, account for the reduction in neural stem cell numbers following the 
exposure to ethanol; the changes in the NPM1 expression may be less important in the cultured neuron 
and astrocytes, though, where NPM1 was actually increased at 25 mM ethanol and only moderately 
decreased at the highest (100 mM) ethanol concentration.  
The present observations may help to identify novel mechanisms by which chronic alcohol 
exposures in utero exert their cytotoxic effects. It should be obvious that existence of such mechanisms 
does not rule out the role of GABA(A) and/or NMDA receptors in the actions of alcohol including the 
neurotoxicity (Spanagel, 2009, Rae et al., 2014, Rae et al., 2014a, Davidson et al., 1995, Hoffman, 1995). 
Ethanol would interact with the neurotransmitter receptors regardless of the length of the exposure and, as 
recent studies with the anaesthetics propofol, sevoflurane and ketamine suggest, such interactions would 
be cytotoxic for brain stem cells (Sikker et al., 2015, Wang et al.,  2015, Qiu et al., 2015). These data 
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merely suggest that additional mechanisms involving many more protein species (particularly those 28 
protein molecules identified by the present study) could be involved in the process.  
The findings of the study are of particular significance for the understanding of mechanisms 
underlying alcoholism-related conditions such as the foetal alcohol spectrum disorder, especially in 
relation to alcohol interference with the earliest stages of brain development. Given that neurogenesis 
may occur in adult brains, too, the present results could also be relevant for the understanding of changes 
in adult alcoholic brains. 
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Abstract 
 
Long term-exposure of human brain tissue to excessive intake of alcohol is accompanied by 
major neurochemical changes; over two hundred proteins have been reported to alter their levels 
of expression and several neurotransmitter systems have been found to be affected. Studies using 
animal brains and cultured cells show similar patterns of alcohol-related changes. Author used 
post mortem brain tissue to investigate effects of chronic alcohol on two nuclear proteins 
mucleophosmin (NPM) and dead end homology-1 (DND1). Both these proteins are likely to be 
involved in the regulation of transcription and translation but they could interact with many 
additional systems. Using western blotting author has found that, in the tissue from the human 
prefrontal cortex exposed to chronic excessive alcohol, NPM was decreased by 43% and DND1 
increased by 80%, compared to controls. The author then applied proteomic methodologies to 
establish with which proteins NPM and DND1 can interact. NPM showed apparently specific 
interactions with 55 proteins, classified as related to cell growth (4), cell structure (4), 
metabolism (18), oxidative stress response (5), signalling (8), apoptosis and DNA damage (2), 
epigenetics (2), transcription (7) or as transmembrane proteins (5). DND1 interacted with 24 
proteins; related to cell growth (1), cell structure (2), metabolism (13), oxidative stress (3), 
signalling (3) and transcription (2). Therefore, NPM and DND1 can influence a broad spectrum 
of mechanisms which are fundamental for normal functioning of brain cells. Particularly striking 
are the numerous associations of the two proteins with metabolic enzymes, including those of 
NPM with Na+,K+-ATPase and DND1 with 4-aminobutyrate (GABA) transaminase. Any 
perturbations of these proteins could impact the signal conduction and synaptic transmission; 
Na+,K+-ATPase provides energy for neuronal activity by maintaining the Na+ and K+ 
transmembrane gradients and drives neurotransmitter-inactivating transporters. GABA 
transaminase metabolizes and regulates the most important inhibitory neurotransmitter GABA. 
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Introduction 
 
Protein-protein interactions 
The human genome consists of more than 30,000 coding genes capable of transcribing in excess 
of 500,000 distinct proteins of which about 10,000 can be produced by the cell at any given time 
(Berggard et al., 2007). It has been estimated that over 80% of proteins function as complexes. 
Protein-protein interaction (PPI) is a key characteristic of all known forms of life both at the 
level of individual cells and protein molecules and in the function of the organism as a whole. 
Specific PPIs enables the system to constitute and balance the vast array of biochemical and 
biophysical reactions necessary to support the life.  PPIs play an important role in regulating 
various biological mechanisms including DNA replication & transcription, enzyme-mediated 
metabolism, transmembrane trafficking, signal transduction and cell cycle control (Berube et al., 
2005).  Identification and characterization of PPI provides important clues as to the biological 
functions of proteins both in health and disease.  
PPIs can be studied in vivo, in vitro and in silico. The in vivo techniques such as the 
hybridization of two yeast cells (Y2H, Y3H) require the use of living cells. In silico studies 
utilize methodologies of theoretical chemistry; protein molecules are constructed in virtual 
spaces and their potential to interact is evaluated under a variety of simulated conditions. Author 
has opted for an in vitro approach, using a method based on a combination of co-
immunoprecipitation (coIP) and mass spectrometry (MS), because of its high sensitivity to detect 
a broad spectrum of PPI’s in a complex biological sample (Khacho et al., 2008, Ma et al., 2012, 
Huang and Kim, 2013).  In this approach an antibody against a protein in the PPIs which author 
wishes to investigate is immobilized by crosslinking to the commercially available protein A/G 
beads and allowed to bind the specific antigen along with the interacting species. After removing 
non-specifically bound proteins by repeated washing, the co-immunoprecipitated interacting 
partners can be eluted from the beads by using a succession of low and high pH media. The 
eluted proteins are separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), digested 
by proteases, and identified using tandem MS (MS/MS; Huang and Kim, 2013). The technique is 
highly sensitive; for example, over 70 proteins have, in this way, been shown to be associated 
with a glutamate receptor protein (Genda et al., 2011). 
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Protein expression in brain cells and tissues exposed to alcohol 
In previous studies author has analysed, using proteomics, various regions of alcoholic human 
and rat brains (human: Kashem et al., 2007, Matsuda-Matsumoto et al., 2007, Matsumoto et al., 
2007, Kashem et al., 2008, Hargreaves et al., 2009, Kashem et al., 2009a, Kashem et al., 2016; 
rat: Kashem et al., 2012) and have identified 238 (out of 7000 detected proteins) proteins as 
being altered in alcohol-affected brain tissue. These proteins were functionally classified as 
cytoskeletal (16%), metabolic (42%), oxidative stress-related (15%), signaling (22%) and 
apoptosis-related (5%). In a recent study (Kashem et al., 2018) author has detected 28 proteins 
which were altered in alcohol exposed rat neural stem cells, neurons and glia; these can also be 
classified as metabolic (21%), cytoskeletal (10%), signal transduction (14%), nuclear (such as 
transcriptional factors; 24%), molecular chaperones and stress-related (21%) proteins as well as 
some (10%) with no identified role (Kashem et al., 2018). From the above studies, it seems 
obvious that alcohol perturbs the cell physiology and, in the process, alters the levels of certain 
proteins. Among those found to be altered by the alcohol exposure six were nuclear proteins and 
transcription factors but none were proteases implying that alcohol may have a greater impact on 
the synthesis rather than the degradation of proteins. Author focused on two of the nuclear 
proteins: nucleophosmin (NPM) and dead end homology-1 (DND1) (Kashem et al., 2018). 
Nuclear proteins nucleophosmin (NPM) and dead end homology-1 (DND1) 
NPM has been reported to regulate, or, be involved in, histone chaperon activity, ribosome 
biogenesis & transportation, genomic stability & DNA repair, endoribonuclease activity, 
centrosome duplication during cell cycle, regulation of ARF-p53 tumor suppressor pathway, 
RNA helix destabilizing activity, and inhibition of caspase-activated DNase and prevention of 
apoptosis (Lindstrom, 2011). Its expression was decreased 1.68 fold in the alcohol-exposed cells 
(Kashem et al., 2018). NPM has three variants; the variants NPM1 and NPM3 have been 
reported as playing important roles in chromatin decondensation and remodelling (Lindstrom, 
2011). A recent study using FLAG-tag-based affinity purification coupled with LC-MS/MS, 
Haga et al. (2013) identified 106 proteins as potential partners of NPM in Ewing's sarcoma cells 
(Haga et al., 2013).  
DND1 binds to miRNA-targeting sequences of mRNAs, inhibiting miRNA-mediated repression 
which plays the key role in the primordial germ cell survival and migration during the early 
embryonic development in chicken (Aramaki et al., 2009). By performing ribonucleoprotein 
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immunoprecipitation followed by RT-PCR, pluripotency factors (OCT4, SOX2, NANOG, 
LIN28), cell cycle regulators (TP53, LATS2) and apoptotic factors (BCLX, BAX) were found to 
be specifically associated with the HA-DND-1 ribonucleoprotein complex (Zhu et al., 2011). 
Ethanol affected proliferation of stem cells as well as their transformation, leading to an 
astrocytic-like phenotype; this might be interpreted as an indication of alcohol inducing 
abnormal astrocytes in the developing brain and potentially persisting until adulthood (Kashem 
et al., 2018). Such cells may display an early “tolerance” to alcohol and/or impaired genomic or 
biochemical make up. This could be a result of chromatin remodeling involving acetylation of 
histones H3 and H4 as reported by Witt (2010). 
Aims of the study 
The chief aims of the present study are two fold. First, we shall investigate the levels of 
expression of two nuclear proteins (NPM and DND1) in human postmortem brains exposed to 
excessive amounts of alcohol for a number of years. Second, if the expressions of NPM and 
DND1 are altered in the alcohol exposed brains we shall determine their interactomes in non-
alcoholic brain tissue. We shall be using samples of brain tissue taken from the prefrontal cortex 
(PFC). PFC may be the most highly developed and differentiated part of the human brain (Teffer 
and Semendeferi, 2012) and the changes in this area have been previously implicated in 
aetiologies of mental diseases (reviews: Weinberger 1987; Nanitsos et al, 2005; Teffer and 
Semendeferi, 2012). The results will add a new element to our investigations of how chronic 
alcohol affects the human brain structure and function at the molecular level. 
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Materials and methods 
   
Human Brain Tissue 
Post-mortem human brains were obtained from the NSW Brain Bank (University of Sydney).  
Samples were grouped as (i) control (< 20 g of ethanol/day) and (ii) alcoholics (> 80 g of 
ethanol/day) (Table 1). Post-mortem examination of the alcoholic brains indicated that there 
were no apparent complications from Wernicke–Korsakoff Syndrome (WKS) in any of the 
alcoholic brains used in the present study. Alcoholic cases fulfilled the criteria of the Diagnostic 
and Statistical Manual of Mental Disorders IV (DSM-IV) for alcohol dependence (Anonymous, 
1994); the relevant data having been obtained from medical records or from reports by the next 
of kin. The estimations of NPM and DND1 levels in control and alcoholic prefrontal cortices 
(PFC) were done by Western blotting while the interactome studies were performed according to 
the procedures specified in the immunoisolation section, using prefrontal cortex (PFC) from 
control subjects. Ethics approval for the use of human tissue use was granted by the Sydney 
South West Area Health Service (Protocol no X13-0379). 
 Protein extraction 
 Protein extractions were performed according to the method previously described by Kashem 
(Kashem et al., 2007, Kashem et al., 2008, Hargreaves et al., 2009, Kashem et al., 2009a, 
Kashem et al., 2009b, Tang et al., 2009, van Nieuwenhuijzen et al., 2010). In brief, the tissues 
samples were extracted by urea buffer (7 M urea, 2 M thiourea and 1% C7bZO, 40 mM tris-HCl) 
and tissue extract was pelleted at 16,000 g for 20 min at 15 C. The supernatant was reduced and 
alkylated with 5 mM tributyl phosphine and 10 mM acrylamide monomer at room temperature 
for 2 hours. The reaction mixture was quenched using dithiothreitol (DTT) at 10 mM. The citric 
acid was used to acidify the samples to approximately pH 5. The acetone-precipitated pellet was 
air dried and resuspended in buffer consisting of 7 M urea, 2 M thiourea and 1% C7bZO. Total 
protein was quantified according to Bradford (1976) using BSA as a standard.  
Western blot (WB) analysis  
The WB analysis was used to identify and estimate the NPM and DND1 proteins. Analogous 
analysis used to identify the immunoprecipitated (IP) protein is described in the immunoisolation 
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section on SDS-PAGE and In-gel Digestion below. First, we separated the extracted proteins by 
SDS-PAGE as described previously by Kashem et al. (2016). The proteins were then transferred 
to PVDF (polyvinylidene difluoride) membranes according to a protocol described earlier 
(Kashem et al., 2012). The membranes were blocked with 5% skim milk and incubated with 
primary antibodies [(NPM, DND1,(Santa cruiz)] solution. Secondary antibodies (anti-mouse and 
anti-rabbit IgG; Sigma) were added according to the manufacturer's instructions and the resulting 
spots were visualized using an ECL (enhanced chemiluminescence) full spell system (GE 
Healthcare, Australia). The intensity of spots was quantified by commercially available Bio-rad 
software (Bio-rad, Sydney, Australia). 
Immunoisolation of DND1 and NPM Associated Protein 
Immunoisolation of NPM and DND1 associated proteins was performed according to protocol 
described by Pierce CrossLink immunoprecipitation kit (Thermo Scientific, Rockford, USA). 
Acetone precipitated protein was resuspended in CHAPS and 0.5% sodium deoxycholate buffer. 
For pre-cleaning of the lysate, 80 µL of the control agarose resin slurry was added to 1 mg of 
extracted proteins followed by incubation at 4oC for one hour and passaged through a specialized 
Pierce spin column. The flow through the spin column, which can be capped and plugged with a 
bottom plug for incubation or unplugged to remove the supernatant by centrifugation at 1000 g 
for 1 minute, was used for immunoisolation. The protein A/G agarose slurry (20 µL) was washed 
twice with 200 µL PBS buffer, and incubated with 100 µL NMP and DND-1 antibody prepared 
in PBS (10 µL NPM or DND1 antibody +85 µL H2O+5 µL 20X PBS) at 25°C for 30 min on a 
mixer. In parallel, 100 µL of rabbit and mouse IgG peroxidase secondary antibody with the same 
concentration of IgG as that of NPM/DND1 antibody was similarly prepared as the negative 
control. The supernatant was discarded and the beads were washed three times with 300 µL PBS, 
followed by incubation with 50 µL disuccinimidyl suberate (DSS) solution (2.5 µL 20 X 
PBS+38.5 µL H2O+2.5 mM DSS in DMSO) at 25°C for 45–60 min on a mixer. After removing 
the supernatant the beads were washed three times with 50 µL of 100 mM glycine (pH 2.8), 
followed by three wash with PBS. About 500 µg of pre-cleaned protein extract was passed 
through the columns (anti rabbit-NPM, negative control (rabbit -IgG), anti-mouse-DND1 and 
negative control (mouse-IgG).  The columns were washed with washing buffer five times and 
eluted with acidic buffer. The elution was neutralized with high concentration of Tris-HCl 
buffer. 
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SDS-PAGE and In-gel Digestion 
 The eluted proteins were resuspended in SDS-loading buffer (150 mM NaCl, 50 mM Tris-Cl, 
pH 7.5), the mixture was heated at 95oC for 5 min and duplicate samples were prepared from 
protein mixture of 6 PFC protein extracts and pooled samples were loaded onto 12% SDS-PAGE 
(n=3).  One set of samples was stained with Coomassie Brillant Blue (CBB) and other set was 
used in Western blotting to confirm the presence of NPM- and DND1-protein immuniprecipitaed 
(IP) complexes. The IP positive lanes were cut into 2-4 mm pieces and processed according to a 
previously described proteomics protocol (Kashem et al., 2007, Kashem et al., 2008, Kashem et 
al., 2009a). In brief, gel bands were excised and de-stained using 25 mM NHHCO3/50% (v/v) 
acetonitrile (ACN) overnight at room temperature. The gel portions were then dehydrated using 
100% ACN. Each gel piece was incubated with 12.5 ng/mL trypsin (Roche, sequencing grade) 
buffer (sodium bicarbonate buffer) for 45 min at 4 C. After several washings the gel piece was 
incubated at 37 C overnight in 25 mM NHHCO3/0.1% trifluroacetic acid buffer. The peptide 
mixtures were purified from the supernatant using C-18 Eppendorf purification tips. 
 Nano-HPLC MS/MS Analysis 
Purified peptides were resuspended in 0.1% formic acid (FA) and separated using an Eksigent 
nanoLC Ultra 2D Plus system coupled to an AB SCIEX (Framingham MA) TripleTOF 6600 
mass spectrometer. Peptides were initially loaded onto a 300 μm × 10 mm I.D. ProteCol™ C18 
P-120 3 μm HPLC trap column (SGE Analytical Science, Ringwood, Australia) in 2% MeCN, 
0.1% FA at 10 μL/min for 10 mins. Peptides were then eluted by altering the composition of the 
mobile phase from 97% buffer A (0.1% FA) to 40% buffer B (99.9% MeCN, 0.1% FA) over 95 
mins at 300 nL/min directly onto an in-house packed 30 cm × 75 μm I.D. ReproSil-Pur 120 C18 
AQ-3 μm column (Dr Maisch, Ammerbuch-Entringen, Germany) for separation immediately 
prior to injection. The TripleTOF 5600 was operated in data independent acquisition mode with 
the top 15 precursor ions (fulfilling the criteria of charge state between +2 and +5, minimum 
intensity of 120 cps, and m/z between 350 and 1250) selected for MS/MS. Selected ions were 
entered into an exclusion list for 12 s after 1 occurrence. For MS scans, a mass window of 350–
1500 m/z and maximum accumulation time of 250 ms were used, while MS/MS scans were 
conducted using a mass window of 100–1500 m/z, accumulation time of 200 ms, resolution set 
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to unit and with the options for rolling collision energies and adjustment of collision energies.  
Raw MS/MS data were converted to Mascot generic format (mgf) files using Peakview 2.2 (AB 
Sciex Aust. Pty Ltd). Resulting mgf files were used to identify proteins using Mascot search 
engine 2.2.07 (Matrix Science) with setting up the parameters: carbamidomethylation on 
cysteine, plus variable methionine oxidation, peptide mass tolerance at 20 ppm and fragment 
mass at 0.6 Da and using Uniprot’s human (Homo sapiens) database.   
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Results 
 
Western blotting  
Protein extracts from prefrontal cortices (PFC) of human alcoholic and control (non-alcoholic) 
brains were analysed for NPM and DND1 proteins by quantitative western blotting and 
immunoisolation.  NPM was 43% lower in the alcoholic tissue compared to the controls while 
the content of DND1 was 80% higher in the alcoholic brain extracts than in those from control 
brains (Fig 1 a-d).  
 
 
Figure 1.   
Western blot of NPM and DND1and MAP-2 (internal control) (1a,b) in the prefrontal cortex tissue of 
healthy and alcoholic postmortem human brain. Three samples are prepared from the six PFC protein 
extracts. Proteins were immunoanalysed and the bands in 1a were digitized; average values (n=3) plus SE 
are plotted in 1b (--*---, significant at 5%).  Fig 1c and 1d shows the immunoisolation of NPM and DND1 
proteins (n=3). Lane 1 (IgG of either rat or rabbit) and lane 2 (either NPM or DND1) are in gel CBB 
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staining of NPM and DND1. Immunoisolated protein complex were further confirmed through western 
blotting (lanes 3 and 5). Lanes 3, and 5 are anti-IgG and primary antibody (anti-NPM and anti-DND1 
antibodies) immunoislated protein complex respectively. Lane 4 is PFC protein extracted (original 
sample) that treated with either anti-NPM or anti-DND1 antibodies, respectively.  
Interactome  
Author has identified 65 proteins in anti-rabbit NPM samples and 10 proteins in a negative 
control experiment (only rabbit IgG); these 10 proteins were eliminated as not uniquely related to 
NPM. The remaining 55 proteins were considered specifically bound by NPM (Table-1). 
Similarly, a total of 30 bound proteins with 6 non-specifically bound proteins were detected in 
anti-mouse DND1 samples and negative control (mouse IgG), respectively. Therefore, after the 
deduction, 24 proteins were considered as specifically interacting with DND1 (Table 2).   
NPM associated proteins can be categorized as being involved in cell growth (4 protein; 7%), 
cell structure (4 proteins: 7%), metabolism (18 proteins; 33%), oxidative stress (5 proteins; 9%),  
signalling (8 proteins: 16%), apoptosis & DNA damage (2 proteins; 3%), epigenetics (2 proteins; 
3%), transcription (7 proteins; 13%) and as transmembrane structures (5 proteins; 9%). 
Similarly, the twenty four proteins identified as DND1-associated can be classified as related to 
cell growth (1 protein; 4%), structure (2 proteins; 8%), cell metabolism (13 proteins; 54%), 
oxidative stress (3 proteins; 12.5%), signalling (3 proteins; 12.5%) and transcription mechanisms 
(2 proteins; 8%).  
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Table-1. NPM co-IPed proteins from the prefrontal cortex of human post mortem brain lysates identified  
by nano-HPLC–MS/MS of in-gel tryptic digests (see Fig. 1C) using the programmes MASCOT data 
based. 
Protein Class 
 
Protein Name No of 
opeptide 
match 
Accession 
no 
Function 
Cell division Cyclin-Y-like protein 1 4 Q8N7R7 Regulation of cyclin-dependent 
protein serine/threonine kinase 
activity 
Cell division Cycle protein 20 3 Q12834 Acts as a regulatory protein 
interacting with several other 
proteins at multiple points in the 
cell cycle.  
Myocyte-specific enhancer 
factor 2B 
3 Q02080 A transcription factors  and  
control gene expression.  Important 
regulators of cellular 
differentiation and play a critical 
role in embryonic development.  
Protocadherin-16 4 Q96JQ0 Calcium-dependent cell-adhesion 
protein and involves in 
neuroprogenitor cell proliferation 
and differentiation 
Cell-
structural 
proteins 
Protein shroom 3 3 Q8TF72 Controls cell shape changes in the 
neuroepithelium during neural tube 
closure. 
Ankyrin-3 2 Q12955 Participates in the maintenance 
targeting of ion channels and cell 
adhesion molecules at the nodes of 
Ranvier and axonal initial 
segments. 
Synaptopodin 4 Q8CC35 Modulating actin-based shape and 
motility the dendritic spines in the 
telencephalic neurons. 
Desmocollin-2 3 Q02487 It is a cadherin-type protein that 
functions to link adjacent cells.   
Metabolic 
proteins 
Glucose-6-phosphate isomerase 5 P06744 Plays neurotrophic factor 
(Neuroleukin) for spinal sensory 
neurons. 
Isocitrate dehydrogenase (IDH) 4 P48735 Deficiency causes several brain 
tumors 
including astrocytoma,  oligodendr
oglioma and glioblastoma 
multiforme. 
3-phosphoglycerate  
dehydrogenase 
6 P26718 Carbohydrate metabolic enzyme.  
Malate dehydrogenase 3 P40925 Involved in gluconeogenesis 
Acyl-CoA dehydrogenase 4 P11310 Involves in beta-oxidation and lipid 
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(medium) metabolism 
Adenosylhomocysteinase 3 P23526 Activates methyl cycle and plays a 
critical role in the modulation of the 
activity of various 
methyltransferases 
Glutamate dehydrogenase 6 P54385 Catalyzes reversible inter-
conversion of glutamate to α-
ketoglutarate and ammonia 
Propionyl-CoA carboxylase (β)  4 P05165 Catalyses 
the carboxylation  reaction 
of propionyl CoA in 
the mitochondrial matrix. 
UFM1-protein ligase-1 4 O94874 Plays a role in the unfolded protein 
response, mediating the ufmylation 
of multiple proteins in response to 
endoplasmic reticulum stress  
26S protease regulatory subunit 
4 
3 P62191 The 26S protease is involved in the 
ATP-dependent degradation of 
ubiquitinated proteins. 
Retrotransposon like –protein 1 2 B9EK54 Expressed imprinted gene that is 
highly expressed at the late fetal 
stage in both the fetus and placenta 
and essential for maintenance the 
fetal capillaries.  
Titin OS 2 Q8WZ42 Key component in the assembly 
and functioning of vertebrate 
striated muscles 
Fukutin-related protein  2 Q9H9S5 This protein is involved in the 
pathway protein glycosylation, 
which is part of protein 
modification. 
NACHT-domain and WD 
repeat-containing protein 1 
4 Q149M9 May play a role in the control of 
androgen receptor (AR) protein 
steady-state levels. 
Low–density lipoprotein 
receptor-related protein 4 
5 O75096 Plays a key role in the formation 
and the maintenance of the 
neuromuscular junction (NMJ), the 
synapse between motor neuron and 
skeletal muscle. 
Peptidyl-prolyl cis-trans 
isomerase  
2 P62937 Peptidyl prolyl cis/ 
trans isomerases (PPIases) are 
ubiquitous enzymes that catalyse 
the cis/trans isomerisation of 
peptide bonds preceding proline in 
peptides and proteins. 
WD repeat-containing protein 
63 
4 Q81WG1 Testis development protein  
WD repeat-containing protein 
87 
4 Q6ZQQ6 Testis development protein 
93 
 
Oxidative 
stress 
Heat shock 71 kDa protein 7 P11142 Acts as a repressor of 
transcriptional activation 
Stress 70 protein 6 P38646 Implicated in the control of cell 
proliferation and cellular aging. 
May also act as a chaperone 
activity. 
78 kDa glucose regulated 
protein 
5 P20029 Prevent misfolding and promote 
refolding of proteins. Proper 
assembly of unfolded polypeptides 
generated under stress conditions in 
the mitochondrial matrix. 
60 kDa heat shock protein 4 P10809 
NKG2-D type integral 
membrane protein 
5 P26718 Provides both stimulatory and 
costimulatory innate immune 
responses on activated killer (NK) 
cells, leading to cytotoxic activity.   
Signaling 
protein  
 
 
 
 
Phosphoglycerate kinase-1 2 P00558 Involves in glycolytic enzyme and 
may play a role in sperm motility  
cAMP-dependent protein 
kinase 
4 P17612 Phosphorylates a large number of 
proteins in the cytoplasm and 
nucleus and activates cAMP, and 
involves in  cell proliferation and 
differentiation  and regulation of 
microtubule dynamics.  
Sarcoplasmic Ca ATPase 3 O14983 Involves in reuptake of cytosolic 
Ca2+ into the sarcoplasmic 
reticulum.  
Ribosomal protein S6 kinase 
(alphas 3) 
4 P51812 Activation of the transcription 
factors CREB1, ETV1/ER81 & 
NR4A1/NUR77 and involves in 
cellular proliferation, survival and 
differentiation, and repressing pro-
apoptotic function of BAD and 
DAPK1. 
Rho GTPase-activating protein 
29 
4 Q5PQJ5 Activator of Rho-type GTPases,  
TBC1 domain family member 
22A 
2 Q8WUA7 May act as a GTPase-activating 
protein for Rab family protein(s) 
Phostensin 4 Q6NYC8 Phostensin interacts with protein 
phosphatase 1 (PP1). 
Guanin nucleotide-binding 
protein (G-) 
5 P62873 Involves as a modulator or 
transducer in various 
transmembrane signaling systems.  
Trans-
membrane 
protein 
Na+/K+ transporting protein 
ATPase 
6 P05023 Na+/K+-ATPase is an integral 
membrane protein responsible for 
establishing and maintaining the 
electrochemical gradients of Na and 
K ions across the plasma 
membrane. 
Phospholipid transporting 
protein  ATPase 
5 Q9Y2Q0 Acts as aminophospholipid 
translocase at the plasma membrane 
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in neuronal cells. 
Transitional endoplasmic 
reticulum ATPase 
4 P55072 Necessary for the fragmentation of 
Golgi stacks during mitosis and for 
their reassembly after mitosis. 
Coatomer subunit (γ-1) 2 Q9Y678 Binds to dilysine motifs and 
reversibly associates with Golgi 
non-clathrin-coated vesicles in 
protein biosynthetic and 
transporting process.   
Golgi in subfamily A 
membrane 4 
2 Q13439 May play a role in delivery of 
transport vesicles containing GPI-
linked proteins from the trans-Golgi 
network through its interaction with 
MACF1. 
Epigenetic 
regulation 
DNA (cytosine-5)-
methyltransferase 3B 
3 Q9UBC3 Required for genome-wide de novo 
methylation and is essential for 
DNA methylation.   
Adenosylhomocysteinase 3 5 Q96NH2 Multifaceted cellular regulator & 
coordinates several essential 
cellular functions including 
regulation of epithelial HCO3- and 
fluid secretion, mRNA processing 
and DNA replication.  
Transcriptional 
machineries 
NSF1 cofactor p47 3 Q9UNZ2 Reduces the  ATPase activity and 
necessary for the fragmentation of 
Golgi stacks during mitosis.  
Spermatid perinuclear RNA-
binding protein  
3 Q96S19 Involved in spermatogenesis and 
sperm function. Plays a role in 
regulation of cell growth. Binds to 
double-stranded DNA and RNA.  
Mediator of RNA polymerase 
II transcription subunit 16 
2 Q9Y2X0 A coactivator involves in the 
regulation of transcription of all 
RNA polymerase II-dependent 
genes.  
Structure specific endonuclease 
subunit SLX1 
3 Q9BQ83 The structure specific endonuclease 
(SLX1) involves in DNA secondary 
structures generated during DNA 
repair and recombination. 
Putative polycomb group 
protein ASXL1 
4 Q8IXJ9 Involved in transcriptional 
regulation mediated by ligand-
bound retinoic acid receptors and 
peroxisome proliferator-activated 
receptor gamma.  
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Eukaryotic translation initiation 
factor 5A-1 
5 P63241 mRNA-binding protein involved in 
translation elongation. Involved in 
actin dynamics and cell cycle 
progression, mRNA decay and 
probably in a pathway involved in 
stress response and maintenance of 
cell wall integrity. 
ELM2 and SANT domain 
containing protein 1 
4 Q6PJG2 Transcription factor  and regulation 
of transcription from RNA 
polymerase II promoter 
Apoptosis 
and DNA 
damage 
p-53-induced death domain-
containing protein1 
6 Q9HB75 A key adapter protein that links to 
p53 apoptosis pathway and 
activation of the transcription factor 
NF-kappa-B. 
DNA damage binding protein 2 3 Q92466 A protein complex that is 
responsible for repair of UV-
damaged DNA. 
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Table-2. DND1 co-IPed proteins from the prefrontal cortex of human post mortem brain lysates identified  
by nano-HPLC–MS/MS of in-gel tryptic digests (see Fig. 1D) using the programmes MASCOT data 
based. 
Protein Class 
  
Protein Name No of 
peptide 
match 
Accession 
no 
Function 
Cell division Cell division control protein 6 6 P09119 Regulator of DNA replication and 
plays important roles in the cell 
cycle particularly   S 
phase of  mitosis 
Structural 
Protein 
Actin related protein 2 5 P61160 Activating nucleation-promoting 
factor (NPF) mediates the 
formation of branched actin 
networks. 
Vimentin 8 P08670 Vimentins are class-III intermediate 
filaments found in various non-
epithelial cells, especially 
mesenchymal cells.  
Metabolic 
protein 
Malate dehydrogenase 5 P40925 Involves in gluconeogenesis 
Fructose–bis phosphate 
aldolase 
5 P04075 Plays a key role in glycolysis and 
gluconeogenesis.  
Succinyl-CoA:3-ketoacid 
coenzyme A transferase-1 
5 P55809 Key enzyme for ketone body 
catabolism and transfers the CoA 
moiety from succinate to 
acetoacetate 
Phosphoglycerate mutase 1 4 P18669 Carbohydrate metabolic protein 
Isocitrate dehydrogenase 5 P48735 Deficiency causes several brain 
tumors 
including astrocytoma,  oligodendr
oglioma and glioblastoma 
multiforme,  
Pyruvate dehydrogenase E1 4 P11177 The pyruvate dehydrogenase 
complex catalyzes the overall 
conversion of pyruvate to acetyl-
CoA and CO2,  
Cytosolic non-specific-
dipeptidase 
4 Q96KP4 Hydrolysis of dipeptides, 
preferentially hydrophobic 
dipeptides including prolyl amino 
acids 
4-aminobutyrate amino-
transferase 
5 P80404 Conversion of gamma-
aminobutyrate and L-beta-
aminoisobutyrate to succinate 
semialdehyde and methylmalonate 
semialdehyde, respectively.  
Fumarate hydratase 6 P07954 Carbohydrate metabolism 
Aldehyde dehydrogenase 4 P05091 Detoxification of alcohol 
metabolites acetaldehyde also 
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involved in the metabolism of 
corticosteroids, biogenic amines, 
neurotransmitters, and lipid 
peroxidation. 
Aceyl-CoA acetyl transferase  3  9BWD1 Lipid metabolic process and plays a 
major role in ketone body 
metabolism 
ATP synthase 4 P06576 Mitochondrial membrane ATP 
synthase produces ATP from ADP 
in the presence of a proton gradient 
across the membrane.  
Ubiquitin-conjugating 
enzyme E2 
6 Q9ULV8 Acts as an E3 ubiquitin-protein 
ligase, which accepts ubiquitin 
from specific E2 ubiquitin-
conjugating enzyme 
Oxidative 
stress 
Heat shock 71 kDa protein 4 4 P11142 
 
Acts as a repressor of 
transcriptional activation and 
inhibits the transcriptional 
coactivator activity of CITED1 on 
Smad-mediated transcription. 
Na+ channel protein type 10 5 Q6R2W3 RNA polymerase II transcription 
factor activity 
ATP-binding cassette 
subfamily A member 13 
4 O14678 ABC-type metal ion transport 
system permease component 
Signaling 
protein 
Guanin nucleotide-binding 
protein (beta) 
5 P18872 Adenylate cyclase-modulating G-
protein coupled receptor signalling 
pathway 
Pyruvate kinase  4 P14618 Glycolytic enzyme that catalyzes 
the transfer of a phosphoryl 
groupfrom phosphoenolpyruvate 
(PEP) to ADP, generating ATP. 
Phosphoglycerate kinase 3 P00558 Glycolytic enzyme and acts as a 
polymerase alpha cofactor protein 
and play a role in sperm motility  
Transcription 
machineries 
Zinc Finger protein 257 4 Q9Y2Q1 Regulation of transcription 
Elongation factor 1-alpha 1 4 P68104 
 
Promotes the GTP-dependent 
binding of aminoacyl-tRNA to the 
A-site of ribosomes during protein 
biosynthesis 
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Discussion 
 
General: Changes in protein composition of brain tissue chronically exposed 
to alcohol 
 Practically all conceivable biological phenomena involve interactions of proteins. Identification 
and mapping of these interactions is fundamental to the understanding of how cells, organs and 
organisms function, reproduce, grow, develop and die. In previous proteomic studies author 
detected 238 proteins as having been altered in human and animal brains following chronic 
exposure to alcohol. Additionally, a recent metabolomic study of human alcoholic striatum 
suggested that long term excessive intake of alcohol can have a potent effect on several 
neurotransmitter systems and may even adversely impact the brain defences against oxidative 
stress and neurotoxicity (Kashem et al., 2016). All these findings represent a significant body of 
neurochemical evidence correlating with the common notion that a chronic exposure to large 
doses of alcohol profoundly alters the homeostasis of brain tissue and that such changes underlie 
the abnormal brain development, cognitive deficits, addiction and other manifestations of 
alcoholism in humans.  
In recent experiments using neural stem cells (Kashem et al., 2018) author has observed that 
several days of exposure to 50 mM alcohol significantly affects expression of nearly 28 
important proteins; these included NPM and DND1. NPM is involved in early brain 
development, cell proliferation and embryonic morphogenesis (Grisendi et al., 2005, Pfister and 
D’Mello, 2015, Xian et al., 2016) while DND1 may also play part in the male reproductive 
process (Aramaki et al., 2009, Youngren et al., 20015, Zhu et al 2011). In the present study, the 
levels of both NPM and DND1 have also been found to be altered in the adult brain alcoholic 
tissue. Rather than delving into how the long-term alcohol exposure might impact any specific 
mechanism directly involving the two proteins in cell physiology, the remaining discussion 
focuses on associations of these two macromolecules with other proteins (“interactomes”) as 
they have been detected in the present study. More to the point, it examines how the altered 
expressions of NPM and DND1 in alcoholic tissue could perturb the cell and tissue functions via 
indirect effects mediated by their interactomes.  
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In the following discussion the proteins are broadly categorized according to the functional and 
structural classes as specified in Tables 1 and 2 but only the proteins and categories potentially 
involved in mechanisms most likely to be affected by alcoholism are included.  
a. Proteins interacting with nucleophosmin (NPM) 
1. Proteins involved in the cell cycle and cell division 
Of the 55 proteins interacting with NPM, 4 (7%) are classified as being involved in cell cycle, 
e.g. cyclein Y like protein 1 and cell division cycle protein 20 (Cdc20). In G1 phase of the cell 
cycle, centrosomes serve as the main microtubule-organizing centre and, as such, their presence 
and normal functioning are crucial for the process of cell replication. A failure of microtubule 
organization would lead to an inability to form proper mitotic spindle resulting in a malfunction 
of cell division (Pfister and D'Mello, 2015).  The G1/S transition is regulated by cyclin E/cyclin-
dependent kinase 2 (CDK2) phosphorylation and Okuda et al. (2000) demonstrated that NPM is 
bound to unduplicated centrosomes and alters cyclin E/CDK2 activity (Okuda et al., 2000). The 
complex between Cdc 20 and NPM has been reported to be involved in mitosis and it binds to 
APC/C (Anaphase-promoting complex or cyclosome). This complex is an essential component 
of the mechanism responsible for the clustering of synaptic vesicles at the active zone of the 
presynaptic membrane (Gieffers et al., 1999, Wang et al., 2016a). Thus any alteration in the Cdc-
NPM complex may adversely impact on the mechanism of neurotransmitter release and could, 
together with the changed metabolism and decreased levels of neurotransmitters (Kashem et al., 
2016), further add to the corruption of synaptic signalling in alcoholism (Spanagel, 2009).  
Cyclin Y-like protein 1 (CLYP1) is another example of a protein identified as a partner of NPM. 
It is able to interact with Cyclin B/CDK1 complex (Jiang et al., 2009) suggesting that alcohol 
could interfere with the stem cell division. This process may involve Wnt signaling as indicated 
by a report of CLYP1-mediated mitotic Wnt signaling in the murine embryonic development and 
in the function (proliferation) of stem/progenitor cells (Zeng et al., 2016).  
Myocyte enhancer factor-2 protein is a transcription factor regulating cell differentiation and is, 
therefore, likely to be involved in embryonic development (Pon and Marra, 2016). 
2. Structural proteins.  
Several structural proteins (four or 7%) have been detected as partners of NPM. Protocadherin 
(Pcdhs) is from a cadherin superfamily of homophilic cell-adhesion proteins. A cluster of Pcdhs 
100 
 
proteins has been detected throughout the neuronal soma, axons, and dendrites (Junghans et al., 
2008, Hulpiau and van Roy, 2009). Ankyrin binds to various other membrane and structural 
proteins such as vimentin, microtubule-related proteins and spectrin. It plays a key role at 
the axonal initial segment of both central and peripheral neurons (Lambert et al., 1997). 
3. Signalling proteins  
Signaling proteins such as kinases, ATP-driven transport proteins and several metabolic enzymes 
were also contributing to the NPM interactome. Author cannot be certain whether the NPM 
interactions with some of these enzymes are direct or whether NPM binds another protein which, 
in turn, is a part of a greater complex or aggregate containing the above species. For example 
malate dehydrogenase binds αB-crystallin and the complex interacts with HSP70 (Mattoo and 
Goloubinoff, 2014, Park and Seo, 2015) which could then bind NPM (Table-1). Such a triprotein 
complex could be important in alcohol-exposed tissue because it is a part of the cellular 
chaperone network of HSP’s that may act by preventing the aggregation of selected proteins 
under stress conditions by maintaining them in a folding-competent state and facilitating their 
liberation from aggregates in an active form via an ATP-dependent chaperone activity (Clerico et 
al., 2015, Park and Seo, 2015). The issue of protein complexes/aggregates may have to be 
addressed in greater detail by future studies involving additional proteins and their interactions 
(and perhaps misfoldings) in alcoholic brain tissue. 
4. Proteins related to metabolism and energy production 
If the expression and/or function of isocitrate dehydrogenase (ICD, Table-1), a key regulating 
enzyme of the NADH-producing TCA cycle, is affected by the low levels of NPM, the main 
source of energy and reducing power in the cells may be seriously compromised. This adverse 
status could be further compounded by simultaneous perturbations of another NPM-associated 
protein glutamate dehydrogenase (GDH, Table-1) which catalyzes the reversible interconversion 
of glutamate to α-ketoglutarate and ammonia (α-ketoglutarate is a substrate of another key TCA-
regulating enzyme α-ketoglutarate dehydrogenase). Moreover, GDH expression itself is reduced 
by long-term excessive alcohol (Kashem et al., 2016). This could cause chronic malfunction of 
the TCA cycle resulting in deficient production of NADH (and ATP) thus further exacerbating 
the vulnerability of the brain tissue to oxidative stress caused by lower levels of GSH (Kashem et 
al 2009; Kashem et al., 2016). 
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Another component of the NPM interactome is Na+/K+-ATPase. This enzyme is particularly 
important in brain tissue; it maintains the ionic gradients across the neuronal membranes which 
are a conditio sine qua non for the maintenance of resting potentials as well as the generation and 
propagation of action potentials. The enzyme also provides the driving force - and interacts with 
- the normally very efficient glutamate transport mediated by the highly abundant transporters 
GLT1 and GLAST; these molecules may contribute to a functional complex in the astrocytic 
plasma membrane which not only transports glutamate but also regulates metabolism and blood 
flow (Pellerin and Magistretti, 1997, Abe and Saito, 2000;, Nanitsos et al., 2004, Moussa et al., 
2002, Moussa  et al., 2007, Bauer et al., 2012, Robinson and Jackson, 2016, Langer et al., 2017, 
reviews: Robinson et al., 2003, Sery et al., 2015). Increased expression of GLAST is one of the 
largest neurochemical changes linked to chronic alcohol exposure (Flatchscher-Bader et al., 
2008, reviews Spanagel, 2009, Sery et al., 2015, but see also Alshehri et al., 2017) and any 
perturbation of the apparently NPM-associated enzyme Na+/K+-ATPase in alcoholic brain tissue 
would almost certainly compromise the normal function of glutamate transport and would have 
major consequences for the function and survival of brain neurons (Sheldon and Robinson, 
2007). 
The glycerolaldehyde-3-phosphate dehydrogenase (GAPDH), a protein with links to the control 
of reactive oxygen species (ROS), nuclear trafficking and signalling is known to be altered in 
brain tissue chronically exposed to alcohol (Kashem et al., 2012). It should not, therefore, be 
surprising that GAPDH has emerged among the proteins interacting with NPM. In response to 
oxidative stress, GAPDH undergoes S-nitrosylation followed by association with E3 ubiquitin-
protein ligase (SIAH-1). The GAPDH-SIAH-1 complex moves from cytoplasm to the nucleus, 
where it participates in the regulation of gene expression and apoptosis (Tristan et al., 2011). 
Furthermore, Lee et al., (2012), using primary neural cultures, noted that the NPM can protect 
against N-methyl-D-aspartate (NMDA)-mediated excitotoxicity by inhibiting the SIAH1-
GAPDH death cascade (Lee et al., 2012). Eukaryotic translation elongation factor 1 delta 
(EEF1D) is also known to interact with SIAH-1 and, as such, it acts as its negative regulator (Wu 
et al., 2011). Author has recently shown that alcohol increases EEF1D expression in NSC 
(Kashem et al., 2018) and the presently identified links of EEFD1 with alcohol exposure 
sensitive expression of NPM further underscores its importance in complex mechanisms by 
which cells respond to the presence of alcohol. 
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5. Response to oxidative stress 
Alcohol-exposure of rat neural stem cells, cultured neurons and glia (Kashem et al., 2018) 
resulted not only in lower levels of NPM but also in significantly altered expressions of several 
forms of heat shock proteins (HSP) such as HSP 71, HSP 70 and HSP 60. All these, plus HSPA5 
(78 kDa glucose-regulated protein precursor), have now been identified as contributing to the 
NPM interactome in human brain tissue (Table-1). NPM and the interacting HSP’s may be 
linked to protective mechanisms mitigating oxidative damage (Liu et al., 2012) and their altered 
expressions in the alcohol-treated (Kashem et al., 2018 ) cells could reflect a response to the 
oxidative stress associated with alcohol exposure. Present data suggest that the response could 
involve interactions between NPM and HSP. Such interpretation appears plausible, given that 
HSP are known to interact with other proteins while promoting resistance to oxidative stress in 
the process. For example, interaction of glucose 6 phosphate dehydrogenase (G6PD) with 
phosphorylated homo-oligomers of heat shock protein beta-1 (HspB1) has been shown to result 
in a significant stimulation of oxidoresistance (Arrigo, 2013). 
6. Proteins involved in transcription, translation, epigenetics and neuronal survival  
Out of the 55 protein molecules associated with NPM about 41% belong to the class of 
DNA/RNA regulating proteins such as eukaryotic initiation factor (eIFs), ELM2 and SANT 
domain containing protein 1, spermatid perinuclear RNA-binding protein (SPRBP), 
retrotransposon-like protein 1, mediator of RNA polymerase II transcription subunit 16, 
structure-specific endonuclease subunit SLX1, eukaryotic translation initiation factor 5A-1, 26S 
protease regulatory subunit 4, Sp110 nuclear body protein, DNA damage-binding protein 2 
(DDB2), adenosylhomocysteinase and DNA methyltransferases 3B (DNMT3B (Table 2). The 
protein eIFs is involved in the initiation phase of the eukaryotic translation process and promotes 
cell viability and cell growth  (Wang et al., 2016b). It is a modulator of the protein synthesis and 
it is involved in the progression of the cell cycle, cellular proliferation and apoptosis (Sharma et 
al., 2016). This factor is also thought to facilitate protein synthesis by participating in the nuclear 
export and plays an important role in chaperon activity (Aitken and Lorsch, 2012). The gene 
SLX1 encodes a protein that is an important regulator of genome stability. This protein represents 
the catalytic subunit of the SLX1-SLX4 structure-specific endonuclease, which can resolve DNA 
secondary structures during repair and recombination processes (Fricke and Brill, 2003; Coulon 
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et al., 2004). The SPRBN is expressed at high levels in testis, ovary and brain; a mutant of this 
gene, if expressed in the sperm flagellum, causes defective motility of the sperm (Pires-daSilva 
et al., 2001) but its role in brain is unknown.  
Adenosylhomocysteinase regulates methylation cycle and a deficient expession of this protein 
has been linked to hypermethioninemia (Palmer and Abeles, 1979). As DNA methyltransferases 
(DNMT’s) use S-adenosyl methionine (SAM) for donation of the methyl group to DNA and the 
enzymes are strongly expressed during early embryo development, any alterations of the activity 
of adenylhomocysteinase could have an impact on a wide range of mechanisms involving DNA 
methylation from early differentiation to adult epigenetics (Maresca et al., 2015, Saitou and 
Miyauchi, 2016, Tognini et al., 2015).  NPM may also interact with the human DDB2 protein 
which is involved in transcription and cell cycle regulation (Ghosh et al., 1996). Deficient 
expression of DDB2 could, in turn, be causally linked to a reduction in p21 protein which is a 
potent inhibitor of cyclin-dependent kinase (Kisielewska et al., 2009).  The expression of p21, 
which, as the present data suggest, might be dependent on NPM, activates gene transcription by 
de-repressing p300–CREBBP (CREB-binding protein) and regulates p53-mediated apoptosis 
under cellular stresses (Abbas and Dutta, 2009);  p53 involves transcriptional activation of pro-
apoptotic genes and inhibits the anti-apoptotic genes. For example, p53 transcriptionally 
activates expression of BID and BAX (Chipuk et al., 2004) and induces apoptosis (Kashem et 
al., 2009a). These findings, therefore, indicate a potential relationship between NPM abundance 
and neuronal survival. This is interesting because NPM has also been linked with death induced 
domain protein 1 (PIDD) a protein acting as an effector of p53-dependent apoptosis (Berube et 
al., 2005) and recently shown to be aberrantly expressed in alcohol-affected brain tissue 
(Kashem et al., 2017). Thus, the NPM expression level could be a critical factor in determining 
the life and death of neurons in brain chronically exposed to alcohol. 
b.  Proteins interacting with dead end homology-1 (DND1) 
1. Are DND1 and associated proteins critical for the survival of dividing cells? 
The changes in DND1 expression presently seen in the human PFC (Fig 1) are in line with our 
recent findings that, following a four-day long exposure to alcohol, DND1 levels significantly 
increase in the cultured rat neural stem cells, neurons and astrocytes (Kashem et al., 2018). What 
could be the significance of an increased expression of DND1 in alcohol-exposed brain tissue? 
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The RNA-binding protein DND1 plays a key role in the primordial germ cell survival and 
migration at early embryonic development stage (Kedde and Agami, 2008) and this might be 
related to what author has observed in the neural stem cells (Kashem et al., 2018). The increase 
in DND1 expression could reflect, for example, a compensatory response by the transcription 
and/or translation apparatus of developing cells to potentially deleterious effects of alcohol. Such 
interpretation would seem to be strengthened by the observations suggesting that DND1 function 
is essential to maintain viable germ cells; its defects are known to produce sperm sterility and 
induce testicular germ cell tumours in mice (Youngren et al., 2005, Zhu et al., 2011). In fact, 
inactivation of DND1 in mice leads to progressive loss of germ cells and eventual male sterility 
(Bhattacharya et al., 2007). But what could one expect in the adult alcoholic brain tissue 
expressing abnormally high levels DND1?  
Previous reports have shown that DND1 protects 3'-untranslated regions (UTR’s) against 
miRNA-mediated gene suppression (Kedde and Agami, 2008). This is probably related to the 
key role of DND1 in the primordial germ cell survival and migration (Kedde and Agami, 2008). 
In the context, it is interesting that the present study has identified cell division control protein 6 
(CDC6) as being part of the DND1 interactome (Table 2). CDC6 protein is essential for initiation 
and regulation of DNA replication and localizes to the cell nucleus at cell cycle phase G1 
(Wlodarchak and Xing, 2016); further translocation of this protein being directed via 
phosphorylation by CDKs (Kisielewska et al., 2009).  What seems, however, the most important 
is that CDC6 can promote DNA hyperreplication inducing a senescence response similar to that 
of oncogene activation; its deregulation has been discussed as a serious risk of cancer (Borlado 
and Mendez, 2008). This is an intriguing suggestion since deregulation of CDC6 in the presence 
of such highly abnormal levels of DND1 as observed in the present study seems quite probable. 
If this indeed triggers the process of cancerous growth, the actions of DND1 (present in excess) 
could be instrumental in further spreading the cancer given the similarities between the migrating 
embryonic cells and the metastatic cancer (Kedde and Agami, 2008, Zhu et al., 2011). To 
author's knowledge, links between alcoholism and brain tumours have not been systematically 
explored; above considerations indicate that research in this direction could be very worthwhile. 
2. Proteins related to carbohydrate metabolism 
In the DND1-protein “interactome”, more than half of the proteins are related to the metabolism 
of carbohydrates. DND1 is usually thought to be involved in transcription so it is somewhat 
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intriguing why it should display such an apparent involvement in carbohydrate metabolism. One 
plausible explanation is that alcohol causes aggregation of many proteins and if any of the 
aggregated species possesses a DND1 binding epitope, all of such proteins may appear as 
“interacting” with DND1. Alternatively, as heat shock proteins have an ability to bind number of 
proteins and, since, HSP’s are binding partners of DND1, the bound proteins may also appear as 
DND1 partners. 
3. Miscellaneous DND1-associated proteins: Role of DND1 in cell differentiation and 
apoptosis? 
Number of transcripts such as encoding pluripotency factors (OCT4, SOX2, NANOG, LIN28), 
cell cycle regulators (TP53, LATS2) and apoptotic factors (BCLX, BAX)  have been previously 
detected by RIP (ribonucleoprotein immunoprecipitation) technique as interacting with DND1 
(Zhu et al., 2011). Author has now identified zinc finger protein 257 and elongation factor 1-1 
() in the postmortem brain tissue (Table 2) as interacting partners of DND1.  The  elongation 
factor 1 () is involved in the recruitment of aminoacyl-tRNA to the A-site of the 
80S ribosome at protein synthesis  (Itagaki et al., 2012, Rehman et al., 2012) and it also plays a 
central role in the nuclear export process (Khacho et al., 2008). Additionally, DND1 interacts 
with many mRNAs including those of both anti- and pro-apoptotic factor, BCLX and BAX (Zhu 
et al., 2011). It should be noted that Zhu et al., 2011 used embryonic stem cells while the present 
study is looking at a proteomic DND1 interactome and does so, for the first time, using adult 
human brain tissue (Zhu et al., 2011). 
Concluding Remarks 
The above interactions and the proposed mechanisms in which they may participate are based on 
both current and previous observations and, combined with the detected changes in the 
expressions of the two nuclear proteins NPM and DND1; they come some way towards 
explaining the damage to brain tissue which accompanies severe alcoholism. The presented 
discussion of possible interactions and their consequences is not intended to be exhaustive; this 
would be beyond the scope of the discourse. Rather, it offers examples of pathways which could 
be involved in the deleterious effects of long term excessive consumption of alcohol on brain 
ranging from synaptic malfunction and neurodegeneration to an increased risk of cancer. 
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Author should be aware of the limitations of the “interactomic” approach as discussed e.g. by 
Robinson and Jackson (2016). The proteins detected as “interacting” may do so only after the 
solubilization of the tissue and may not necessarily have a ready access to each other in vivo. 
This could be either because of their fixed separate locations in membranes or because they exist 
in distinct cells and/or compartments. In the case of nuclear proteins DND1 and NPM, however, 
it would be difficult to argue against genuine in vivo interaction with proteins known to be 
involved in DNA- or RNA-dependent mechanisms taking place in the nucleus or its immediate 
vicinity. Other findings, such as the multiple interactions with metabolic proteins are more 
difficult to justify but possible explanations are mentioned in the text. 
It seems also obvious that the conclusions of the present study do not directly imply that the 
changes in DND1 and NPM are “pimary” consequences of alcohol exposure; changes in their 
levels may have resulted from altered levels/functions of their interacting proteins or, indeed, 
through any other mechanism linked to alcoholism.  
In conclusion, the present study offers an extensive set of data which will be useful in future 
studies targeted at nuclear proteins such DND1 and NPM and their role in changes taking place 
in brain tissue exposed to excessive long term consumption of alcohol. 
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Impact of Alcohol in the Young 
 
A.  Impacts on Developing Brain: 
i. Impact on Adolescent Brain: Evidence suggests that adolescent brain is particularly 
sensitive to alcohol relative to adult. Individuals who start to drink prior to 14 years of age are 4 
times more likely to progress to addiction than those who do not commence using  of alcohol 
until  the age of  21 (Hingson et al., 2002, Grant,1998). Animal models revealed that alcohol 
intake in adolescence significantly increases the risk for alcohol-related problems and alcohol-
dependence in later life (Füllgrabe, et al., 2007) and increases alcohol drinking 2-3 fold 
compared to an average adult drinker who would have started consuming alcohol later in life 
(Füllgrabe, et al., 2007, Siegmund, et al., 2005). The molecular mechanism of alcohol 
involvement in this latent dynamic effect has not been adequately documented.  
Various avenues of research have demonstrated that alcohol exposure disrupts motor 
coordination, causes sedation and social disinhibition in adolescence (Spear, 2000, Spear, 2014, 
Spear, 2015). Experiments in Linda Spear’s lab have demonstrated that adolescent rats are weak 
in digestion with alcohol relative to adult rats, and high level of alcohol is associated with more 
brain damage in their prefrontal cortex region (important for decision making) and in the brain 
regions related to working memory such as hippocampus (Spear, 2000). Repeated exposure to 
alcohol in adolescent rats suggested that long-term chronic alcohol is likely to be responsible for 
dramatic damage in several brain areas, including regions associated with learning (basal 
forebrain) and language acquisition (neocortex). Adolescents who have recently recovered from 
an alcohol dependence disorder revealed weak performance on verbal and non-verbal memory 
relative to a control group with no history of alcohol dependence (Brown et al., 2000), and had 
reduced volume in the hippocampus (Tapert and Schweinsburg, 2004).  
Studies in animal models suggest that synaptic neurotransmission generally develops in utero or 
very early after birth. It does require further fine tuning post partum, through, and this process 
(including a degree of “rewiring”) may continue well into adolescence (Wolff, 1984).  
Neurotransmitter dopamine is thought to be intimately involved with the reward system and 
undergoes pronounced developmental changes during adolescence (Spear, 2014, Spear, 2015). 
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The density of dopaminergic connections to the prefrontal cortex continues to increase during 
the life (Lambe et al., 2000; Rosenberg and Lewis, 1994; Tunbridge et al., 2007). Dopamine 
synthesis and its turnover, and projection of dopamine neurons from prefrontal cortex to the 
striatum are increased from adolescence to adulthood (Andersen et al., 1997; Teicher et 
al., 1993), and this shift of dopamine balance between prefrontal and subcortical structures may 
be, at least in part, due to synaptic “pruning” taking place in the neocortex (Bourgeois et 
al., 1994). The GABAergic neurotramission undergoes profound development during 
adolescence. In rodent (rats), neuron fibers from the basolateral amygdala continue to form 
connections with GABAergic interneurons in the prefrontal cortex throughout periadolescence 
(Cunningham et al., 2002, Wolff, 1984). In non-human primates, GABAergic inputs to 
pyramidal cells undergo changes during the perinatal period and adolescence (Akil and 
Lewis, 1992; Cruz et al., 2003) in concert with continued maturation of behavioral patterns 
mediated by the prefrontal cortex (Cruz et al., 2009). The input to GABAergic interneurons in 
the prefrontal cortex appears to decrease strongly from human adolescence to adulthood 
(Lewis  et al., 2005, Spear, 2000). The various neurotransmitter changes occurring during 
adolescence are in synchrony with the anatomical changes seen in the prefrontal cortex and 
other brain regions during this stage, as well as maturation of cognition and behavior and the 
emerging increased risk for psychopathology (Paus et al., 2008). Alteration of dopamine and 
reward circuitry are critical to assigning value and reinforcing behaviors, such as social 
interaction, food consumption, romantic behaviors, novelty seeking, and alcohol and other drug 
intake (Spear, 2009), while ongoing refinement of inhibitory neurotransmission has broad 
implications for information processing and modulation of brain activity. Thus the alcohol 
consumption and vulnerability of the brain to alcohol’s harmful effects may result in cognitive 
deficits and other problems that persist far beyond adolescence. Furthermore, the long-term 
behavioral changes that follow alcohol exposure during adolescence may involve subtle changes 
in neuronal connections and any potential deficits so caused may come to the surface at much 
later stages of life, including the old age.   
The neurogenesis continues in the postnatal and adult brain in at least two regions close to the 
lateral ventricles [subventricular zone (SVZ)] and in the dentate gyrus of the hippocampus 
[subgranular zone (DGZ)] (Ming and Song, 2011, Fuentealba et al., 2012, Urban and Guillemot, 
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2014). Evidence suggests that the rate of neurogenesis varies with the age of the individual but is 
also influenced by environmental factors like anxiety, depression, drugs and, in particular, by 
alcohol. Pre- and/or postnatally impaired neurogenesis has been reported to result in abnormal 
behavior in later life and during adulthood.  Prenatal exposure to ethanol can have long-lasting 
depressive effects on postnatal neurogenesis in the subgranular zone of the dentate gyrus and the 
abnormalities of this neurogenesis could be linked to deficits in cognitive function in later life 
(Winocur et al., 2006, Klintsova et al., 2007). The above evidence implies that the early exposure 
to ethanol can lead to latent changes in brain which may resurface at a later age, even in 
adulthood. Author has performed proteomics in 96 hour ethanol exposed rat neural stem cell 
(NSC) and identified 28 proteins that showed changed expression; these have been classified into 
following groups: metabolic proteins (13%), cytoskeletal (7%), proteins involved in signal 
transduction (7%), nuclear proteins including transcriptional factors (20%), molecular 
chaperones and stress related proteins (35%), and other (18%) (Kashem et al., 2018). 
Interestingly, nuclear protein nucleophosmin (NPM) expression was found to be decreased 1.8 
fold in alcoholic exposed cell.  NPM is located in the nucleolus and it is transported from 
nucleolus to nucleoplasm during serum starvation and to the cytoplasm by anticancer drugs. It 
regulates the following metabolic functions such as histone chaperon activity, ribosome 
biogenesis and transportation, genomic stability and DNA repairing, endoribonuclease activity, 
centrosome duplication during cell cycle, regulation of ARF-p53 tumor suppressor pathway, 
RNA helix destabilizing activity, inhibition of caspase-activated DNase and has been reported to 
prevent apoptosis (Qing et al., 2008). Ethanol at high concentration (50 mM) affected 
proliferation of stem cells and their transformation, leading to an apparently abnormal astrocytic 
phenotype; this phenotype alteration indicates that alcohol can modify intrinsic cellular 
mechanisms of stem cell which might in part be responsible for subsequent defective astroglial 
and  neuronal functions (Vemuri et al., 2005). Thus, the cells that develop early “tolerance” to 
intoxicating environment might have impaired genomic or biochemical make up. Significantly, 
this may be a result of  alcohol-related remodeling of the chromatin through acetylation of 
histones H3 and H4 in various brain regions (prefrontal cortex, nucleus accumbens, and striatum)  
as reported by many researches (MacDonald et al., 2009, Wit, 2010). This impaired neurons 
continue to develop, will get incorporated into the structure of brain and may confer abnormal 
structural and functional characteristics on whole brain regions.  
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ii. Impact on Fetal Brain: Alcohol induces anatomical (mainly, but not only 
neuroanatomical) and cellular changes in both rodents and humans. Neuroimaging of mice pups 
revealed that alcohol exposure during the gestation period results in malformations analogous to 
those observed in human FASD (Fetal Alcohol Spectrum Disorder), including facial dysmorphia 
and defective brain development. For example, exposure of mice to alcohol on gestational day 
(GD) 7 produces defects in the cerebral cortex, hippocampus and basal ganglia (Godin et al., 
2010); while alcohol use on gestational day 8 produces neuronal death in the hindbrain  and loss 
of ganglia, and abnormalities in fiber tracts (Parnell et al., 2009). Significant neural loss in the 
cortex, brainstem, and subcortical structures of offspring of Macaque monkeys exposed to 
ethanol during early pregnancy has been reported (Farber et al., 2010; Mooney and Miller, 
2009). Loss of cortical neuron in offspring following ethanol exposure during gestation or in the 
postnatal period has been similar in the rodent (Schneider et al., 2011, Thompson et al., 2009). 
Neuroimaging of the human brain has revealed that significant reduction of the volume of 
cerebral cortex, cerebellum, hippocampus and the corpus callosum as observed in adult 
alcoholics are paralleled by similar changes in brain of FASD children (Biran et al., 2012).  
Microstructural alterations of brain regions may be associated with (or even be a result of) 
altered genetic and/or biochemical make up. Protein expression studies in the corpus callosum 
(Kashem et al., 2007, Kashem et al., 2008, Kashem et al. 2009a), prefrontal cortex (Alexander-
Kaufman et al., 2007) and hippocampus (Matsuda-Matsumoto et al, 2007) in post-mortem 
samples of human brain revealed that profound changes in the expression of specific protein are 
directly related to abnormal metabolism known to exist in alcoholic brains. Prolonged heavy 
alcohol consumption caused major changes in the phenotype in FASD-diagnosed offspring but 
low to moderate level of alcohol drinking which does not appear to lead to any phenotypic 
symptoms may nevertheless alter genetic and/or biochemical make up that could gradually result 
in the appearance of secondary symptoms and/or disabilities. Thus, it seems crucially important 
to develop early diagnostic tools and find out treatment strategies which could help timely 
identification of FASD individuals and made early medical intervention possible and effective.  
B. Quest for Alcoholic Biomarker for FASD Diagnosis 
 
Ideal clinical biomarker would be a distinct morphological physiological, biochemical, genetic, 
or molecular trait or substance that is specific to a particular medical condition. In practice, 
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FASD biomarker may not be fully reliable; like routinely used clinical detection system for 
conditions such as diabetes and heart disease, biomarkers in psychiatry and, in particular, in 
FASD would have limitations in clinical diagnosis, perhaps more so than in the somatic 
medicine (Boksa, 2013).  
Chronic and/or heavy alcohol intake during pregnancy causes a wide range of damage to an 
unborn child and results most often in the following abnormalities in the newborn: low birth 
weight, small head circumference, developmental delay, various types of organ dysfunction, 
facial abnormalities, including smaller eye openings, flattened cheekbones and others (Shuler 
and Schroeder, 2013).  Later in life this may extend to attacks of epileptic convulsions, poor 
coordination/fine motor skills, poor socialization skills, difficulty building and maintaining 
friendships, learning difficulty, poor memory, poor problem solving capabilities and serious-
behavior problem including hyperactivity (Loomes et al., 2008, Paolozza et al., 2015, Hunt and 
Barnet, 2015). Depending on the amount of alcohol consumption and the frequency of drinking 
during early stages of pregnancy, still birth, abortion, or preeclampsia may occur (Ornoy and 
Ergaz, 2010). These may be, however, results of advance stages of alcoholism associated with 
previous continuing heavy drinking of alcohol.  
Effects of alcohol involve molecular alterations at the DNA, RNA, protein and metabolite levels. 
Current diagnostics and follow up of most of the alcoholic disorders including neurological and 
neuropsychiatric disorders are based on a set of traditional biomarkers with cluster of symptoms 
and scales. Several alcohol biomarkers such as activities of gamma-glutamyl transferase, 
aspartate aminotransferase, alanine aminotransferase, and carbohydrate-deficient transferin have 
been used for many years. Other biomarkers include mean corpuscular volume, 5-
hydroxytryptophol, serotonin metabolite, fatty acid ethyl esters, ethyl sulfate, phosphatidyl 
ethanol, phosphatidyl ethanolamine and ethyl glucuronide, and biomarkers of alcohol-induced 
tissue injury, such as those for alcoholic liver disease. Other, include alpha-smooth muscle actin , 
fibronectin, collagen type I, serum hyaluronate, matrix metalloproteinases. The author opinionis 
that- an ideal biomarker for alcoholic disorders have the following characteristics: (a) ability to 
diagnose the abnormality resulting from low-to-moderate levels of drinking over extended 
periods of time; (b) high sensitivity for detecting abnormalities during pregnancy, (c) high 
authenticity (low rate of false-positive results), (d) accessibility of biological sample, easy 
analysis with little amount of sample and  simple collection and  preparation technique (e) 
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economical and fast. It is evident that none of the above biomarkers are anywhere near to an 
adequate sensitivity and specificity required for reliable diagnosis of FASD. At presence fatty 
acid ethyl esters (FAEEs) in meconium is employed to identify alcohol exposure during 
pregnancy. However, the biomarker molecules FAEEs do not provide information on the timing, 
duration and dosage of exposure to alcohol (Litten et al., 2010). Moreover, FAEEs do not 
provide information on the extent of damage and/or on the mechanism of alcohol-related injury. 
Thus, there is a significant need for more reliable biomarkers that can be used for FASD 
diagnosis. Such biomarkers should be related to pathogenicity of alcohol, indicating the level of 
existing damage and thus helping to plan the treatment.   
Author has studied differential protein expression in alcoholic post-mortem human/rat brains 
(Kashem et al., 2007, Kashem et al., 2008, Kashem et al., 2009a, Alexander-Kaufman et al., 
2007, Matsuda-Matsumoto et al., 2007, Kashem et al., 2012) and identified 238  proteins that are 
associated with alcohol induced abnormal metabolic disorders. Based on the functions of these 
proteins author selected certain proteins such as tyrosine hydroxylase, dopamine  hydroxylase, 
catechol-O-methyltransferase, DOPA decarboxylase, tryptophan hydroxylase, glutamate 
decarboxylase-2, glutamate synthetase, N-acetylaspartate-glutamate synthetase, glutamate 
carboxypeptidase II, histidine decarboxylase, glutathione peroxidase, glutathione synthase, 
glyoxalase-1, apolipoprotein A-I, triosephosphate isomerase, isocitrate dehydrogenase,  
phospholipase D,  SNAP-25, stathmin, sirtuin-2, DJ-1, α-synuclein, protein phosphatase, 
DARPP-32, CREB, apoptic death agonist (Bid) and cathepsin D as those with the greatest 
potential to become biomarker for alcoholism and alcohol-related disorders.   
In addition to protein expression, author has analysed metabolites, extracted from the tissues of 
the nucleus accumbens, the caudate nucleus and the putamen regions of alcoholic postmortem 
human brain by liquid chromatography-tandem mass spectroscopy (LC-MS/MS). Initial data 
suggest that excessive alcohol drinking significantly alters dopamine, serotonin, 3,4-
dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindoleacetic acid 
(HIAA), norepinephrine (NE), histamine, choline, acetylcholine, gamma-aminobutyric acid 
(GABA), glutamate (Glu) and glutathione and, neurotransmitters particularly DA and 5HT ratio 
(Kashem et al., 2016). Prenatal alcohol exposure reduces the concentrations of catecholamines, 
indolamine, and amino acid neurotransmitters (GABA, Glu) in E13 fetal mice brains (Sari et al., 
2010). This study suggests that alterations of selective neurotransmitters may be useful for 
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biomarker of FASD (Sari et al., 2010). However, several other molecules such as polyamines 
(PA), the naturally occurring di-, tri-, and tetra amines, are closely related to the neuronal activity 
of the brain via interactions with neurotransmitter receptors (N-methyl-D-aspartate receptor), 
regulation of substances in degenerating cells and protecting neurons from oxidative damage 
(Spalloni et al., 2013). In mammals, cellular polyamines (PAs) (putrescine, spermidine and 
spermine) derive from ornithine.  This may be significant because alcohol is known to alter the 
metabolism of PAs in the cells. Moreover, administration of PA can reduce ethanol consumption 
in rats genetically predisposed to drinking without producing signiﬁcant side effects (Bilbeny et. 
al., 2005). Therefore, it would seem important to study the endogenous concentrations of PA in 
the brain and other tissue of alcoholic humans and animals in order to better understand the role 
(and potential benefits) of PA in alcoholism.  
C. Impact of Alcohol on Male Reproductive System -Paternal FASD 
Those who get used to drinking regularly while young may find it difficult to stop when they 
reach to the age of reproduction. Birth defects characteristic of FASD have almost universally 
been thought of as associated with the mother drinking during pregnancy.  To date no known 
safe amount of alcohol or safe time to drink alcohol seems to have been identified for male or 
female who intend to have a family. It has been virtually assumed that fetal FASD would be 
prevented if mother abstains from alcohol during pregnancy; however father’s contribution to 
FASD has not been adequately considered. It used to be thought that the offspring is not 
significantly affetcted by paternal drinking but alcohol consumed by the male can lead to a 
variety of problems in the male reproductive system particularly in the quality of sperm (Lee et 
al., 2013). When children of fathers who are drinkers and non-alcoholic mothers are compared 
with those diagnostic with FASD, the children of the drinking fathers are usually not grossly 
malformed, but they do have certain intellectual and functional deficits in common, and they are 
also more likely to be hyperactive (Kim et al., 2014).  
Alcohol abuse can have a particularly negative effect on the male reproductive system resulting 
in infertility, hormonal problems and various sexual disorders. The molecular mechanisms by 
which alcohol impact on the system at cellular level remains virtually is unknown. Studies on 
Danish young army man (age 18-25 of 1221 individuals) have shown that regular intake of 5 
units (50 ml or 40g ethanol daily; standard drink in Australia is 10 g) alcohol was associated with 
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a significantly higher levels of the serum free testosterone and sperm level up to 33% lower 
compared to nondrinkers (Jensen et al., 2014).  
Mammalian spermatozoa consist of a head, neck and tail and contains lots of proteins and also 
have enzymes that for solubilization of the membrane of oozyte. The nucleus of the sperm 
condenses chromatin with the genetic information. By proteomics study using mature human 
sperm Wang et al., identified 4675 proteins; of which 227 are testis specific (Wang et al., 2013). 
Oliva and Castillo suggested that 56% of sperm nuclear proteins have a potential to be involved 
in epigenetic mechanisms such as chromosome organization, chromatin organization, protein-
DNA complex assembly, DNA packaging, gene expression, transcription, chromatin 
modification and histone modification (Oliva and  Castillo, 2011). Chronic alcohol and cocaine 
is associated with significant decreases various miRNA levels in the testis (Bielawski et al., 
2002: Ouko et al., 2009). MiRNAs are small molecules that interfer the protein expression and 
sperm contained various precursors and mature miRNAs. Several sperm miRNAs such as mmu-
mir-133b-3p, -196a-5p, 205-5p, 340-5p,9 29c, 30a, 30c, 32, 193-5p, 204, 375, 5323p, and 698 
that author previously reported as altered in fathers sperm due to this high fat diet, stress and 
obesity (Fullston et al., 2013). Interestingly, mir-133b-3p is up-regulated 3 fold in the sperm of 
high fat diet father (Fullston et al., 2016). Author recently found that C. elegans animals lacking 
miRNAs, miR-83 (human homologs, hsa-29) and miR-245 (hsa-133) both show a dramatic 
increase in oxidative stress resistance and lifespan extension (Kashem et al.,unpublished data) 
and deletion of mir-133 induced dopamine synthesis and activates behavioral aggregation in 
Locusts (Yang et al., 2014). Moreover, microinjection of mir-34c inhibitor into zygotes inhibited 
DNA synthesis and significantly suppressed first cleavage division (Liu et al., 2012) and 
this miRNA is highly abundant in the brain and body tissues where its expression is increased in 
ethanol-exposed mouse liver (Meng et al., 2012).  Another mir-124 is decreased by alcohol (Kim 
et al., 2014) and injection of this brain developing miRNA into the fertilized eggs resulted in 
progeny that exhibited a 30% larger body size relative to normal, and this giant phenotype 
persisted up to F2 generation; after that the body size of the descendants reverted back to normal 
(Grandjean et al., 2009). Beside the implication of miRNAs on male reproductive system, 
Author has proposed a specific hypothesis which has been published and is presented in full 
below.  
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Hypothesis: 
Could Ethanol-Induced Alterations in the Expression of Glutamate 
Transporters in Testes Contribute to the Effect of Paternal Drinking on the 
Risk of Abnormalities in the Offspring? 
 
Based on a paper published in Medical Hypothesis  (Kashem et al., 2017. Medical 
Hypothesis, 98: 57-59). 
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Abstract 
 
It has been known that a preconception paternal alcoholism impacts adversely on the offspring 
but the mechanism of the effect is uncertain. Several findings suggest that there are signalling 
systems in testis that are analogous to those known to be altered by alcoholism in brain. Author 
proposed that chronic alcohol affects these systems in a manner similar to that in brain. 
Specifically, author hypothesise that excessive alcohol may disturb glutamatergic-like signalling 
in testis by increasing expression of the glutamate transporter GLAST (EAAT1). Author discuss 
ways how to test the hypothesis as well as potential significance of some of the tests as tools in 
the diagnostics of chronic alcoholism. 
 
Background 
 
Presence of apparent cognitive deficits in children fathered by heavily drinking men has been 
known since antiquity (Ouko et al., 2009). The mechanism(s) by which paternal alcohol-drinking 
inflicts damage on the offspring remain(s), however, obscure. It has been suggested that the 
DNA in male gametes affected by alcohol is altered epigenetically, e.g. by an interference in the 
methylation of DNA cytosine but the evidence, particularly when obtained in humans, is scarce 
and may be contradictory. Some groups have reported a decrease in the expression and activity 
of a DNA methyltransferases (Ouko et al., 2009, Bielawski et al., 2002) resulting in a failure of 
orderly suppression of specific DNA sites in male-contributed alleles (Ouko et al., 2009). In 
contrast, results of other studies, using male mice exposed to ethanol, implied that an increased 
methylation of specific DNA loci, e.g. cytosine-rich sequences (“CpG islands”) in the promoter 
region of the DAT gene encoding a dopamine transporter, could be at fault (Kim et al., 2014). 
Disturbed expression of DAT has, indeed, been causally linked to an attention-
deficit/hyperactivity disorder (ADHD)-like behaviour similar to that observed in the offspring of 
the ethanol-exposed male mice (Kim et al., 2014); (cf. review of animal models of ADHD 
(Russel, 2011) and altered expression of DAT1/SLC6A3 in human ADHD (Šerý et al., 1999). 
Here authors propose an alternative hypothesis which, in their view, fits better the broad 
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spectrum of deficits encountered in the offspring of alcoholic males. It is based on the probable 
presence in the testis of signalling mechanisms similar to those known to exist in the central 
nervous system. 
The main synaptic transmitters in brain are L-glutamate (excitatory) and GABA (inhibitory); (for 
a historical review see (Bennett and Balcar, 1999). Both glutamatergic and GABAergic synapses 
are thought to be strongly involved in mediating the effects of alcohol (Spanagel, 2009, 
particularly via the NMDA-type of glutamate receptor and the alpha4-subunit containing 
GABA(A) receptor (Rae et al., 2014, Lovinger et al., 1990, Allgeier, 2002). Both GABAergic 
and glutamatergic signalling systems, including the two types of receptors mentioned above, are 
altered in alcoholism (Kashem et al., 2016, Bekdesh and Herison, 2015, Davidson et al., 1995, 
Burnett et al., 2016). Interestingly, it is not only the synaptic receptors which are affected by 
alcohol but also the neurotransmitter-inactivating mechanisms that are changed in alcoholic 
brains, particularly in the case of glutamatergic neurotransmission. 
In the central nervous system (CNS), synaptically released L-glutamate is inactivated by several 
specific transporters located mainly but not exclusively in the plasma membrane of surrounding 
astrocytes. There are five genes coding for the transporters (reviews: [Zhu and Danbolt, 2013, 
Sery et al., 2015]) but protein products of two of them predominate: GLAST transporter encoded 
by SLC1A3 and GLT1 transporter encoded by SLC1A2. GLT1 and GLAST are also referred to as 
EAAT1 and EAAT2, respectively, particularly when discussing human brains. Both transporters 
require Na+ and K+ transmembrane gradients as the driving force  to transport L-glutamate from 
the extracellular space (reviews: [Zhu and Danbolt., 2013, Sery et al., 2015]). In addition, 
GLAST acts as a chloride-selective ligand- (L-glutamate-) gated channel and thus has a 
capability to hyperpolarise GLAST-expressing cells in the presence of L-glutamate [review: Sery 
et al., 2015]. Both GLAST and GLT are mostly expressed in the central nervous system (Zhu 
and Danbolt, 2013, Sery et al., 2015); the only other tissue which expresses them in significant 
quantities is testis (Redecker et al., 2003, Hu et al., 2004, Hu et al., 2004, Takarada et al., 2004, 
Lee et. al., 2011). 
In the testes, GLT1 (EAAT2) has been detected in the interstitial cells but it is located mainly in 
the seminiferous tubules, both in the Sertoli cells and in the sperm. GLAST is found, apart from 
the Sertoli and interstitial cells, in the sperm, apparently in its anterior part, possibly concentrated 
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in the acrosome (Hu et al., 2004, Takarada et al., 2004). The other glutamate transporters that 
have been detected in the testes are EAAT5 which acts mostly as an L-glutamate-gated chloride 
channel (Wersinger et al., 2006, Veruki et al., 2006) and EAAT3 (Hu et al., 2004, Takarada et 
al., 2004).  
The precise role of glutamate transporters in the testes is not known. However, L-glutamate is 
the most abundant free amino acid in testis (Setchell et al., 1967) and is present inside the 
seminiferous tubules. Moreover, the compartment is separated from the blood stream by a very 
tight blood-testis barrier formed by tight junctions in the Sertoli epithelium. The presence of L-
glutamate (together with several “synaptic” proteins; cf. [Hu et al., 2004] and receptors [(Hu et 
al., 2004, Takarada et al., 2004)]) sequestered behind such barrier would seem to imply that a 
signalling apparatus, possibly involving germ cells and sperm, both in their mature and immature 
forms either dormant or active and mediated by L-glutamate, exists and functions in testes. 
Glutamate transporters would then provide a regulating (“inactivating”) mechanism analogous to 
that functioning at brain synapses (reviews: [Bekdesh and Herison, 2015, Davidson et al., 1995). 
Alternatively, L-glutamate transport, mainly by GLAST (EAAT1) and EAAT5 could trigger 
chloride influx thus hyperpolarizing and activating the sperm (Lee  et al., 2011).  
The Hypothesis 
It has been reported that chronic exposure to large doses of alcohol is associated with significant 
(several-fold) increases in the expression of GLAST (EAAT1), both in mice and men 
(Rimondini et al., 2002, Flatcher-Baader and Wilce, 2008). Should a similar overexpression of 
GLAST (EAAT1) occur in testes under similar circumstances (chronic severe alcoholism), 
sperm would become much more susceptible to the activation than the sperm of non-alcoholic 
males possibly leading to a formation of active immature sperm. Subsequent fertilization by such 
immature sperm would significantly increase the risk of developmental defects in the offspring 
(Tesarik, 1998).  
Evaluation 
It should be understood that the developmental defects caused by the paternal alcoholism are 
distinct from the better known Foetal Alcohol Spectrum Disorder (FASD) and would be entirely 
independent of the alcoholic status of the pregnant female. The hypothesis does not negate the 
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role of epigenetics as a mediator of the effect of paternal alcohol consumption on the offspring; 
there is ample evidence for such mechanisms from rodent studies (for a review see [Lee et al., 
2010]). The present hypothesis adds, however, an extra element to the picture and could help to 
explain the complexity of the phenomenon (Finegersh and Wilce, 2015). 
Testing the hypothesis would present several significant challenges. Firstly, glutamate 
transporters are expressed in a number of splice variants and the splicing pattern in the testes 
appears very different from that in the CNS (Veruki et al., 2008). Use of single antibodies 
against GLAST (EAAT1) or GLT1 (EAAT2) in the testicular tissue could, therefore, easily miss 
or underestimate the full extent of the changes in GLAST (EAAT1) expression putatively caused 
by chronic alcoholism. Suitable antibodies against a range of splice variants are available (Lee et 
al., 2010, Lee et al., 2012) though not yet on commercial basis. The glutamate transporter 
immunohistochemistry would have to be complemented by in situ hybridization using 
judiciously selected antisense oligonucleotides to reveal the full extent of the changes and their 
loci. Secondly, not just the presence but also the function of GLAST (EAAT1), GLT1 (EAAT2) 
and EAAT5 both in the seminiferous tubules and in the sperm would have to be investigated. 
Initial approach encountered significant methodological hurdles (Lee  et al., 2011) but these can 
be overcome. Given the proposed hypothetical importance of the transporter molecules in the 
sperm activation, samples of sperm should perhaps be used directly in this type of studies. 
Thirdly, a link between the proposed overexpression of GLAST in the testes and/or in the sperm 
following chronic exposure to alcohol and observed deficits in the offspring would have to be 
established. This experimental component seems crucial in testing the validity of the hypothesis 
but may also be the most difficult, probably requiring a large (inter-disciplinary) animal-based 
approach. In the meantime, GLAST (EAAT1) expression in the sperm of alcoholic men could be 
looked at and perhaps evaluated as a possible diagnostic test for the severity of chronic 
alcoholism. 
Conclusion and Significance of the Hypothesis 
It is  proposed that the mechanism of the effect of paternal alcoholism on inborn deficits in the 
offspring can be at least in part explained by a changed pattern of the expression of glutamate 
transporters in the testes of alcoholic fathers. This would involve, in particular, overexpression of 
GLAST (EAAT1) glutamate transporter. Testing the hypothesis presents significant 
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methodological challenges but none of them seem in principle unsurmountable. Additionally, the 
tests could yield an important diagnostic tool potentially useful in assessment of chronic 
alcoholism in men. Should the hyperactivity of glutamate transporter GLAST be an important 
part of the mechanism, there is extensive pharmacological information on structural requirements 
of glutamate transporters that could greatly facilitate design and synthesis of specific inhibitors 
(Balcar, 2002, Bridges and Esslinger, 2005). 
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D.  Consequence of Alcohol on Energy Metabolism in Brain Cells 
In NPM and DND1 interactome studies, 30% of the associated partners of both proteins are 
related to energy metabolism process. Previously, in proteomic studies, author concluded that 
96 (42%) out of 238 proteins could be classified as related to energy metabolism.  These 
findings could be taken as an indication that one of the chief (undesirable) effects of alcohol is 
a disruption of energy metabolism.  It is known that glycolysis, the pentose phosphate 
pathway, and the tricarboxylic acid cycle (TCA) play an important role in ATP production 
and maintaining normal synaptic functions in the CNS (Bolaños et al. 2008). Author has 
previously found the expression of triose phosphate isomerase (TPI), glycerol-3-phosphate 
dehydrogenase (G3PDH) and glyoxalase 1 (Gly-1) significantly up-regulated in the alcoholic 
brain (Kashem et al., 2016, Kashem et al., 2012, Kashem et al., 2009b, Kashem et al., 2008). 
TPI catalyzes reversible interconversion of dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde phosphate (G3P). G3P is further metabolized for formation of ATP via TCA 
cycle. One physiological effect of this reaction is the prevention of the DHAP accumulation in 
the organism, which can otherwise be transformed into methylglyoxylate (MG), a toxic 
compound that interferes with a variety of metabolic processes (Danise et al., 1999) (Figure 
1). It has been found that when red blood cells were incubated with 50 mM glucose for 2 hr, 
MG and triose phosphates were accumulated and this accumulation of MG was prevented by 
thiamine supplementation (Thonrnalley et al., 1998). Author identified the thiamine and/or 
other vitamin biosynthesis enzymes are altered by alcohol (Kashem et al., 2016, Kashem et 
al., 2012, Kashem et al., 2008). However, G3PDH plays a pivotal role in distinct metabolic 
functions which include: (1) generation of glycerol-3-phosphate for phospholipid and 
triglyceride biosynthesis, and (2) conversion of glycerol-3-phosphate to DHAP during 
gluconeogenesis.  Glycerol-3-phosphate dehydrogenase has been identified in the brain 
(Kashem et al., 2008, Kashem et al., 2012, Leveille et al., 1980) which forms glycerol-3-
phosphate during phospholipid synthesis. The increased activity of G3PDH in both the white 
matter (WM) (Morland et al., 2007) and the body of the CC (Kashem et al.,  2009b), suggests 
that alcohol accelerates the synthesis of phospholipids or induces the reversal of carbon flow 
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towards DHAP (Figure 1). Previous studies (Kashem et al. 2007; Kashem et al. 2008), TCA 
cycle first ATP generating enzyme isocitrate dehydrogenase (ICD), has been found to be 
decreased in the alcoholic CC (Kashem et al., 2009b). The low expression of ICD in the brain 
cell ceased the maximum capacity to utilize three carbon compounds in the TCA cycle 
leading to redirection of carbon flow towards DHAP formation, concomitantly, decreasing the 
rate of ATP production from glucose (Figure 1). Thus, the high level of DHAP activates the 
accumulation of MG. Author has previously established that the exprression of MG 
detoxifying enzyme, Gly-1 decreased both in rat striatum and human CC (Kashem et al., 
2012, Kashem et al., 2009b, Kashem et al., 2008). The Gly-1 protein expression was increased 
in early Alzheimer (AD) cases and decreased in late AD (Kuhla et al., 2007). Down-
regulation of the Gly-1 in late AD was due to the formation of high level of advanced 
glycation end products (AGEs) (Kuhla et al., 2007). MG reacts with free amino acids and 
thiol-molecules to form AGEs and the high level of AGEs contributes to neuronal death and 
neurodegenerative diseases (Shangari et al., 2005).  
Reactive oxygen species (ROS) are cooperatively and synergistically scavenged for and/or 
degraded by enzyme systems like superoxide dismutases (SOD’s), glutathione peroxidase 
(GPX), glutathione S-transferase (GST) and glutathione reductase (GR) (Yan et al., 2008). I 
previously observed that GPX expression was decreased in the splenium (Kashem et al. 2007) 
and, GST() expression was ceased in alcoholic genu (Kashem et al., 2008). The, GST 
(another isoform) and SOD (Zn2+/Cu2+-dependent in the cytoplasm)  were significantly 
increased in alcoholic tissue compared to control (Kashem et al., 2012, Kashem et al., 2007).  
Superoxide anions (O2
−) are reduced by SOD to form molecular oxygen and hydrogen 
peroxide (H2O2). This H2O2 is reduced by GPX through oxidation of two glutathione (GSH) 
molecules. The oxidized GSH (called glutathione disulfide, GSSG) is subsequently reduced 
by GR under consumption of NADPH (Berkholz et al., 2008). The low expression of ICD in 
this tissue might be correlated with this pathway in relation to NADPH supply. Vogel et al., 
1999 suggested that redox balancing and oxidative damage prevention are the primary 
functions of ICD through the supply of NADPH for glutathione (GSH) redox cycling systems. 
Taken together, it is suggested that alcohol possibly alters the glucose metabolic carbon flow 
towards MG production, leading to starvation of TCA precursor molecules, and concomitantly, 
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decreases the ATP production. The starvation energy (ATP) unable to balancing free radicle 
leading to activates apoptosis signaling pathway (Figure 1).  
 
 
 
 
 
 
Fig. 1. Hypothetical model for accumulation of toxic carbonyl bioproduct, inhibition of 
oxidative stress defense system, cascade of thiamine, and apoptosis signaling of alcoholic 
human brain(glucose 6P, glucose 6 phosphate; fructose 6P, fructose 6 phosphate; TPI, triose 
phosphate isomerase;  1,3 PG, 1,3 phosphoglyceride; DAP, diacetone phosphate; ICD, isocitrate 
dehydrogenase; AR, aldose reductase; MG, methylglyoxal; G3P, glycerol-3-phosphate; G3PD, 
glycerol-3-phosphate dehydrogenase; Gly-1, glyoxalase-1; GPx, glutathione peroxidase; GR, 
glutathione reductase; CaD, cathepsin D, BID, apoptotic death agonist; TCA cycle, tricarboxylic 
acid cycle; GSSG, glutathione disulfide; NADH, nicotinamide adenine dinucleotide; NADPH, 
nicotinamide adenine dinucleotide phosphate.  
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